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Chapter I 
 
Introduction 
 
 
Overview 
 Early fetal lung buds progress through multiple stages to become a highly branched organ 
with an expanded surface area necessary for gas exchange. During the late stages of lung 
development, pre-alveoli saccules form and expand at the end of airways. Bronchopulmonary 
dysplasia (BPD) occurs when development of the fetal lung is arrested at the saccular stage in 
preterm infants (Coalson 2003). Infants with BPD have abnormal lung pathology, with a 
thickened interstitium and reduced surface area available for gas exchange (Chess et al. 2006). 
Even if infants survive BPD, there are serious long-term health consequences, including more 
severe reactions to infections with frequent hospitalizations. Currently, the limited treatment 
options for BPD are steroids, vitamin A supplementation, and oxygen therapy. In many cases, 
these treatments do not resolve BPD (Jobe et al. 2001). Additional research is required to define 
the pathway of fetal lung inflammation and how it leads to BPD. 
Changes in developmental cues directing alveolarization can prevent normal septation of 
saccules into alveoli. Signaling required for airway branching can be disrupted in utero or after 
birth. In utero exposure to infection or ex utero ventilation, hyperoxia, hypoxia, and infection are 
risk factors leading to inhibited lung development (Jobe 2003). These risk factors all initiate 
inflammation in the fetal lung. Proinflammatory cytokines are present in the amniotic fluid and 
tracheal aspirate fluid isolated from infants with BPD (Cayabyab et al. 2003). Identifying the 
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components involved with the inflammatory process in the fetal lung will guide the development 
of new therapies for BPD.  
 Mouse models have linked inflammation with abnormal fetal lung development, but have 
not addressed the source of fetal inflammation. In utero, chorioamnionitis led to abnormal lung 
development in fetal mice. Isolated fetal lung explants exposed to LPS have reduced branching 
and inhibited expression of growth factors required for lung development (Benjamin et al. 2007). 
When IL-1β is overexpressed during lung development, there is abnormal postnatal lung 
morphogenesis (Bry et al. 2007). However, the cells in the fetal lung that detect pathogens and 
produce an inflammatory response remained unidentifed. Using an NF-κB reporter mouse, we 
identified macrophages as the first cell type in mouse fetal lung explants to respond to the 
bacterial endotoxin LPS. Macrophages were also the primary sites of inflammation in the fetal 
lung. Macrophage activation was required and sufficient to alter fetal lung morphogenesis. We 
inhibited macrophage activation by depleting macrophages and deleting IKKβ in macrophages. 
Macrophage depletion and inhibition of NF-κB protected fetal lung explants from the effects of 
LPS. When we activated NF-κB in macrophages, lung morphogenesis was disrupted, resulting in 
a BPD-like phenotype. After identifying macrophages as the main cell type driving 
inflammation, we directed our research to focus on the capabilities of fetal lung macrophages. 
Fetal lung macrophages isolated in vitro could polarize in response to varying stimuli. However, 
fetal lung macrophages respond differently in vivo. Isolated macrophages showed that NF-κB 
activation in vivo does not completely polarize fetal lung macrophages, but induces their 
maturation. The two fetal macrophage subpopulations, CD11bhiF4/80lo and CD11bloF4/80hi, 
became skewed during inflammation. With NF-κB activation, there was an increase in the 
CD11bloF4/80hi subpopulation of fetal lung macrophages, and these macrophages shared similar 
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marker expression with mature alveolar macrophages. Fetal lung macrophages have inherent 
changes after activation. We have shown the importance of macrophages in fetal lung 
inflammation. 
Proinflammatory cytokines are present in the fetal lung of infants with BPD. IL-1β has 
been suggested as the specific proinflammatory cytokine responsible for abnormal lung 
development (Bry et al. 2007). To produce IL-1β, the inflammasome is required for processing 
and release of the active IL-1β peptide. Blocking IL-1β activity, using a neutralizing antibody to 
IL-1β, protected fetal lung explants from the effects of LPS. Inhibiting the effector component of 
the inflammasome, caspase1, also protected fetal lung explant branching from LPS. Important 
inflammasome components are developmentally regulated, with increased expression during the 
saccular stage. Both IL-1β and the inflammasome contribute to abnormal lung morphogenesis, 
and both are strong drug targets to quench fetal lung inflammation. 
Prior to this research, it was unknown which cells in the fetal lung were responsible for 
the inflammatory response. We have identified the cell type necessary for fetal lung 
inflammation, the macrophage. Through NF-κB activation in macrophages, the fetal lung has 
disrupted airway development. Fetal lung macrophages are capable of polarizing in vitro, but 
have a unique, complex response to NF-κB in vivo that does not follow the polarization 
paradigm. By recognizing the large role macrophages have in fetal lung disease, we can begin to 
understand what factors are involved in fetal inflammation and direct the course of future 
research in fetal macrophage biology. 
 Many potential areas of fetal macrophage research can have large impacts for infants 
with BPD. The jobs of macrophages throughout lung development have not been well 
characterized. Further, it is unknown how these roles can change during a state of homeostasis to 
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inflammation. There may be differences in the roles of fetal macrophage subpopulations as well. 
Due to the large role macrophages have in fetal lung inflammation in mice, there is likely a 
parallel role for macrophages in the lungs of infants with BPD. Future studies will focus on 
samples acquired from BPD patients to receive potential therapeutics and determine how 
macrophages change. Our research provides a new target cell for treatment options for BPD that 
could potentially be more effective and successful. 
 
Developmental Progression of Lung Morphogenesis 
 In the mouse, the fetal lung develops from two simple buds into a highly organized and 
branched network efficient at gas exchange. The endoderm and mesoderm become an 
interconnected tree-like structure that continuously provides oxygen to the body. Initially, the 
ventral foregut endoderm is specified as future lung tissue (Cardoso and Lü 2006). After 
specification, there are five distinct stage of lung development, occurring both pre- and 
postnatally. The embryonic stage of lung development begins on gestation day 9.5 (E9.5) and is 
defined by two lung buds protruding from the endoderm into the surrounding mesoderm 
(Morrisey and Hogan 2010). Further elongation and separation of the lung buds from the 
endodermal tube form the main bronchi and trachea (Morrisey and Hogan 2010). 
 After the main branches are formed in the early mouse fetal lung, multiple rounds of 
regulated branching form the tree-like structure during the pseudoglandular stage. The 
pseudoglandular stage occurs from E12.5 to E16.5. The fetal lung undergoes highly routine 
stereotypical branching to form a network of bronchi and bronchioles (Metzger et al. 2008). 
Following lung bud extension and elongation, lung bud tips swell and bifurcate (Metzger et al. 
2008). Tightly controlled signaling and cross-talk between the endoderm and mesoderm are 
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required for regulated and stereotypical branching to occur. Adjacent endoderm and mesoderm 
each release combinations of branching activators and inhibitors. Fibroblast growth factor 10 
(FGF-10) is produced in the mesoderm adjacent to the tips of distal lung buds and is essential for 
fetal lung branching (Bellusci et al. 1997). FGF-10 deletion during development prevents fetal 
lung formation (Min et al. 1998). FGF-10 induces proliferation and elongation in epithelial cells 
at the tips of branching airways (Park et al. 1998). Sonic hedgehog (Shh) expressed in the distal 
epithelium and negatively regulates FGF-10 expression to inhibit branching in the wrong 
location (Bellusci et al. 1997; Chuang et al. 2003; Lebeche et al. 1999). In the mesenchyme, 
transcription growth factor β (TGFβ) inhibits branching along the stalks and in between airways 
(Heine et al. 1990; Serra et al. 1994; Zhao et al. 1996). The mesothelial lining of the lung 
produces FGF-9 to signal the mesenchyme to increase FGF-10 expression (del Moral et al. 
2006). By the end of the pseudoglandular stage, these processes have completed branching of the 
bronchial tree, resulting in terminal end buds that will eventually give rise to the lung respiratory 
units. 
 After the large airway network is established in the fetal mouse lung, the formation of the 
distal airways beings during the canalicular stage. From E16.5-E17.5 the distal buds narrow, 
becoming respiratory bronchioles and alveolar ducts. In addition to increased branching, 
vasculature development occurs, increasing fetal lung size (Morrisey and Hogan 2010). The 
saccular stage occurs from E17.5 until birth. During the saccular stage, the ends of the distal 
buds form small sacs that become alveoli (Warburton et al. 2010). Additionally, the interstitium 
begins to thin and both the epithelial and mesenchyme differentiate (Warburton et al. 2010). 
Epithelial and mesenchymal cell differentiation is important to form the thin structure of alveoli 
and blood vessel needed for gas exchange. The distal epithelium will differentiate into thin type I 
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cells, involved in gas exchange, and type II cells, producers of surfactant (Rawlins et al. 2009). 
The mesoderm differentiates into myofibroblasts, airway smooth muscle cells, pericytes, and 
vascular smooth muscle cells (Morrisey and Hogan 2010). Blood vessels are arranged adjacent to 
type I epithelial cells for gas exchange (Morrisey and Hogan 2010). The final stage of lung 
development, the alveolar stage, begins at birth and is completed at postnatal day 30 (P30) in 
mice (Warburton et al. 2010). During alveolarization, the saccules undergo further division to 
increase the overall surface area available for gas exchange. While airway branching ceases 
postnatally, the lungs continue to grow from the elongation of airways and septation of alveoli 
(Morrisey and Hogan 2010).  
 
Bronchopulmonary Dysplasia and Disrupted Lung Development 
Bronchopulmonary dysplasia (BPD) is a chronic lung disease found in the smallest 
preterm infants. Up to 50% of very low birth weight (<1000g) preterm infants, or approximately 
10,000 infants, develop BPD every year (Christou and Brodsky 2005). Infants are diagnosed 
with BPD after oxygen dependence for 28 postnatal days (Baraldi and Filippone 2007). Preterm 
infants born during the late canalicular or early saccular stage, between 24-28 weeks, are the 
most at risk for developing BPD (Coalson 2003). Lung histology from BPD patients shows 
dramatic morphological changes. Their lungs have large airways surrounded by a thickened 
interstitium (Chess et al. 2006). Due to inhibited alveolar septation, there is reduced surface area 
available for gas exchange (Chess et al. 2006). To stifle inflammation and aid lung function, 
corticosteroids, surfactant replacement, vitamin A supplementation, and oxygen have been used 
as therapies (Jobe et al. 2001). Even with current treatment options, 20-40% of infants with BPD 
do not survive (Christou and Brodsky 2005). Of those that do survive, there are long-term effects 
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from sustained lung damage (Jacob et al. 1998).  After BPD, children have an increased 
likelihood of developing respiratory infections and an increased frequency of re-hospitalization 
(Smith et al. 2004). 
 There are many risk factors that increase the likelihood of developing BPD.  Preterm 
birth is one of the main risk factors for BPD.  The largest risk factor for preterm birth is 
chorioamnionitis, the inflammation of the placenta and extra-embryonic structures due to 
infection (Romero et al. 2002). Approximately 87% of preterm births delivered before 27 weeks 
gestation are born to mothers with chorioamnionitis (Chess et al. 2006). Infections causing 
chorioamnionitis can have multiple different bacteria present, including Ureaplasma 
urealyticum, Mycoplasma hominis, Staphylococcus aureus, and Escherichia coli (Romero et al. 
2002). There is a strong association between the presence of IL1β, neutrophils, and macrophages 
in preterm lungs and maternal chorioamnionitis (Cayabyab et al. 2003). Other risk factors for 
BPD are postnatal infection, resuscitation, hyperoxia, and mechanical ventilation (Jobe 2003). 
All of these risk factors can induce the production and release of proinflammatory cytokines 
(Jobe 2003). Chorioamnionitis may have a role priming the fetal lung for inflammation, as BPD 
occurs most often in infants with chorioamnionitis and either infection or are on a ventilator 
(Watterburg et al. 1996). Exposure to multiple risk factors increases the likelihood of BPD (Jobe 
2003). 
 While many risk factors have been identified, the mechanism of BPD development is still 
being researched. Animal models of chorioamnionitis have been helpful to study lung 
development during inflammation. Intra-amniotic injections of endotoxin in fetal lambs induced 
a proinflammatory cytokine response in extraembryonic structures and the fetal lung (Kallapur et 
al. 2001). While inflammatory cytokines were observed to induce lung maturation, the number of 
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alveoli was reduced by a third (Willet et al. 2000). IL-1β is one of the proinflammatory cytokines 
detected in the amniotic fluid of infants born with BPD (Watterburg et al. 1996). A mouse model 
inducing IL-1β expression in the fetal lung led to an abnormal postnatal lung morphology, 
resembling BPD (Bry et al. 2007). Saccular stage IL-1β expression impaired alveolarization and 
angiogenesis (Bry et al. 2007). Using lung samples from BPD patients, mesenchymal cell were 
disorganized and there was reduced FGF-10 expression (Benjamin et al. 2007). Similarly, a 
mouse model of chorioamnionitis also shows reduced FGF-10 expression in fetal lung and 
irregular smooth muscle actin staining (Benjamin et al. 2007). It is clear that inflammation is a 
major factor in BPD development and it affects the signaling factors needed for lung 
development. However, research is still needed to define the inflammatory pathway leading to 
BPD.  
 
Development of Fetal Lung Macrophages 
 Macrophages were named and described by Mechnikov in the 1890’s after he first 
visualized the uptake of microorganisms by phagocytosis (Ovchinnikov 2008; Lichanska and 
Hume 2000). Macrophages are part of the innate immune system and classified as leukocytes, or 
white blood cells (Geissmann et al. 2010). Part of the leukocyte family is the mononuclear 
phagocytes, which encompass hematopoietic derived cells of the myeloid lineage (Geissmann et 
al. 2010). Adult hematopoiesis begins with a hematopoietic stem cell that matures into myeloid 
precursors followed by a promonocyte stage. Promonocytes develop into monocytes, which 
mature into macrophages (Shepard and Zon 2000).  
 Before the bone marrow has developed, early embryonic hematopoiesis occurs at 
different locations. In the early embryo, macrophages are first detected in the yolk sac prior to 
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the start of hematopoiesis and circulatory development (Lichanska and Hume 2000). The first 
population of macrophages within the yolk sac is maternally-derived and are thought to be a 
transient population used for short term support (Bertrand et al. 2005). After maternal 
macrophages colonize the yolk sac between E7-7.5, fetal-derived myeloid precursors are 
detected in the yolk sac mesoderm at E8 (Bertrand et al. 2005). These myeloid precursors 
develop by yolk sac myelopoiesis within blood islands, a process called primitive hematopoiesis. 
Yolk sac myelopoiesis is unique in that macrophages develop from precursors that bypass an 
intermediate monocyte stage (Bertrand et al. 2005).  
 The third population of myeloid cells in the yolk sac develops from hematopoietic stem 
cell (HSC) precursors. HSC precursors enter circulation and migrate to the aorta-gonad-
mesonephros (AGM) region in the E9 embryo (Cumano and Godin 2007; Ovchinnikov 2008). 
After populating the AGM, HSCs develop from the aorta region of the AGM (de Bruijin et al. 
2000). HSCs then colonize the fetal liver at E10.5, which marks the beginning of fetal 
hematopoiesis (Cumano and Godin 2007; Medvinsky et al. 2011). HSCs in the fetal liver 
undergo hematopoiesis, also called definitive hematopoiesis, to expand and differentiate (Orkin 
and Zon 2008; Ovchinnikov 2008). After fetal liver hematopoiesis begins, there is a drastic 
increase in the number of macrophages throughout the embryo (Ovchinnikov et al. 2008). The 
spleen and bone marrow, which sustain adult hematopoiesis, are colonized by HSCs at E12.5 and 
E16.5, respectively (Medvinsky et al. 2011). 
 Multiple factors are required for a HSC to develop into a macrophage. HSCs are first 
specified as myeloid progenitor cells, which then become committed monocyte precursors. The 
transcription factor c-Myb is required for HSCs to develop into myeloid progenitor cells, while 
PU.1 is required for the differentiation of myeloid progenitors (DeKoter et al 1998; Schulz et al. 
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2012). c-Myb is expressed by myeloid progenitors, and its expression is reduced as these 
progenitors differentiate (Mucenski et al. 1991). In the absence of c-Myb, myeloid progenitors 
are severely reduced in the fetal liver (Mucenski et al. 1991; Sumner et al. 2000). In addition, 
CD11b+F4/80+ macrophages were found in the yolk sacs of Myb-/- embryos, further supporting 
the role of c-Myb in HSC differentiation (Schulz et al. 2012). PU.1 is a transcription factor 
expressed in cells derived from hematopoietic precursors, including B cells, macrophages, and 
granulocytes (McKercher et al. 1996). When PU.1 is absent, these populations are missing in 
neonates (McKercher et al. 1996; Scott et al. 1994). Differentiated stem cells derived from PU.1-
/- embryos express early myeloid markers but are missing late myeloid markers (Olson et al. 
1995). PU.1-/- hematopoietic cells did not express Csf1r, leading to an inhibited response to 
macrophage colony-stimulating factor (M-CSF) (Anderson et al. 1998; DeKoter et al. 1998). 
This indicates PU.1 is required for myeloid progenitors to differentiate into cell-specific lineages, 
but is not required for HSCs to become specified as myeloid and lymphoid progenitors 
(McKercher et al. 1996; Scott et al. 1994; DeKoter et al. 1998). PU.1 regulates transcription of 
other myeloid-specific genes, including M-CSF, granulocyte-macrophage colony-stimulating 
factor (GM-CSF), colony-stimulating factor receptor 1 (Csf1r), lysozyme M, CD11b, and IL1β 
(Hohaus et al. 1995; Lichanska et al. 1999; Pahl et al. 1993; Smith et al. 1996; Zhang et al. 
1994). The growth factor M-CSF is necessary for myeloid progenitors to become monocytes and 
macrophages. M-CSF binds Csf1r and is a factor required for progenitor cell development into 
macrophages (Stanley et al. 1983). M-CSF induces proliferation and differentiation of myeloid 
progenitors and macrophages (Stanley et al. 1983). The absence of M-CSF reduces the number 
of monocytes and macrophages, but does not alter progenitor cell number (Wiktor-Jedrzejczak et 
al. 1982; Wiktor-Jedrzekczak et al. 1990; Yoshida et al. 1990).  
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Macrophage Function and Polarization Response 
Macrophages have a variety of functions that are niche-specific. Macrophages are 
required for trophic roles in tissues, such as branching morphogenesis, angiogenesis, and 
efferocytosis. When macrophages are absent, mammary gland outgrowth and branching is 
inhibited (Van Nguyen and Pollard 2002). The absence of macrophages prevents normal 
extracellular remodeling and maintenance of mammary stem cell function (Wynn et al. 2013). 
When fetal macrophages are absent during pancreas and kidney development, there are 
abnormalities in tissue formation (Pollard 2009). Macrophages residing in the developing brain 
as microglia secrete factors for neuron growth and survival (Wynn et al. 2013). Fetal 
macrophages regulate angiogenesis in ocular development by inducing apoptosis in extraneous 
endothelial cells (Lobov et al. 2005). A large role for fetal macrophages is efferocytosis, the 
phagocytosis of apoptotic cells. Early in development, fetal macrophages are located in areas of 
high apoptosis, such as the interdigital region of the limb buds (Hume 2006, Sasmono et al. 
2003). When apoptotic cells cannot be cleared, due to the lack of expression of the 
phosphatidylserine receptor, fetal lungs have an abnormal morphology, with reduced airspace 
and a thickened mesenchyme (Li et al. 2003). Fetal macrophages have active roles during 
embryonic tissue development, leading to altered tissue morphogenesis when macrophage 
development and function is manipulated. 
Macrophage function has been used to help categorize the heterogeneity found among 
macrophage subsets. Local microenvironment factors and external pathogens contribute to 
macrophage phenotype polarization. The classical macrophage activation (M1) occurs in 
response to TLR signaling, INFγ, TNF-α, and tumor cell recognition (Martinez and Gordon 
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2014; Sharif et al. 2007). M1 macrophages produce antimicrobial products, such as reactive 
oxygen species, and proinflammatory cytokines as a defense mechanism (Sica and Mantovani 
2012). Macrophages that are not following the traditional response are defined as alternatively 
activated macrophages (M2). In general, M2 macrophages respond to parasitic infection, 
promote wound healing, and encourage tumor progression (Martinez and Gordon 2014). 
However, there are multiple types of M2 macrophages, ranging from M2a to M2d, that have 
different stimuli and responses (Mantovani et al. 2004). IL-4 and IL-13 from injured tissue 
activate M2a macrophages to produce collagen for new extracellular matrix (Mantovani et al. 
2004). When wound healing goes into overdrive and becomes chronic, M2 macrophages 
contribute to fibrosis (Bellon et al. 2011; Haymann et al. 2009). M2 macrophages also express 
high levels of scavenger receptors, phosphatidyl serine receptors, and integrins for the clearance 
of apoptotic cells (Mosser and Edwards 2008). 
Interestingly, NF-κB plays a role in both M1 and M2 macrophage activation. TLR 
signaling activates NF-κB, which increases expression of proinflammatory genes in 
macrophages (Sica and Mantovani 2012). NF-κB is also present during the resolution of 
inflammation, which activates M2 macrophages (Sica and Mantovani 2012). There are disease 
states that have polarized macrophages that contribute to disease progression. M2d macrophages 
are tumor-associated macrophages that promote tumor growth and metastasis (Pollard 2004). 
There are cases of macrophages either changing phenotype or being replaced by macrophages of 
opposing phenotype during disease initiation and progression. M2 macrophages are present in 
the adipose tissue of lean mice, but shift to M1 macrophages during obesity, contributing to 
insulin resistance (Lumeng et al. 2007).    
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IL-1β  Production in Macrophages 
Proinflammatory signaling in macrophages begins with activation of the NF-κB pathway. 
Macrophages have pattern recognition receptors (PRRs) to detect pathogen associated molecular 
patterns (PAMPs), expressed by multiple infectious agents. Specific subsets of PRRs are Toll-
like receptors (TLRs). TLRs are expressed by both immune cells, such as macrophages and 
dendritic cells, but also by non-immnune cells, like fibroblasts and epithelial cells (Kawai and 
Akira 2007). TLRs form a group of more than thirteen receptors that recognize pathogens 
ranging from gram negative and positive bacteria, viral proteins, and fungi (Kawai and Akira 
2007). After TLR activation, downstream signaling requires a complex of adaptor proteins with 
MyD88, IRAK, and TRAF that activate the NF-κB pathway (Rothwarf and Karin 1999) (Figure 
1.1). 
Prior to TLR signaling, NF-κB is sequestered in the cytosol in a non-active form. NF-κB 
is formed from heterodimers (p65/p50) or homodimers (p50/p50), with p65 and p50 forming 
canonical NF-κB (Gilmore 2006). To keep NF-κB in the cytosol, inhibitor of NF-κB (IκB) binds  
and blocks the DNA-binding site of NF-κB (Beg et al. 1992). Upon activation, IκB Kinase 
(IKKβ) phosphorylates IκB, which is ubiquitinated and degraded (Napetschnig and Wu 2013). 
NF-κB is free to translocate into the nucleus and bind transcriptional targets. NF-κB  
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Figure 1.1. TLR4 and IL-1R1 signaling pathway.  After TLR4 and IL-1R1 activation, they share 
intracellular components to activate NF-κB. 
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increases gene expression of many proinflammatory cytokines and chemokines. NF-κB 
activation is transient and cyclical as it becomes activated and deactivated from continuous  
receptor signaling (Gilmore 2006). NF-κB signaling is quenched as IκB is synthesized and binds 
to nuclear NF-κB, blocking it from future activity (Rothwarf and Karin 1999). 
A major target of NF-κB is the proinflammatory cytokine IL-1β. After TLR activation, 
NF-κB increases transcription of IL-1β. IL-1β is initially formed as a p31 propeptide, which 
much be cleaved by the inflammasome into a p17 active peptide (Dinarello 1998). While there 
are different inflammasome models that have varying components, the NLRP3 inflammasome is 
the most characterized at present. The NLRP3 inflammasome regulates the maturation and 
secretion of IL-1β and IL-18 (Petrilli et al. 2007). The inflammasome becomes activated by 
bacteria, fungi, and parasites (Strowig et al. 2012). ATP and the production of reactive oxygen 
species can also induce inflammasome activation (Schroder and Tschopp 2010). The NLRP3 
inflammasome is a multi-protein complex formed with NLRP3, ASC, and cleaved caspase 1 
(Strowig et al. 2012). NLRP3 has a nucleotide binding domain and a caspase recruitment 
domain, which are necessary for its role as scaffolding for the inflammasome (Martinon and 
Tschopp 2007). ASC acts as an adaptor protein for the complex (Schroder and Tschopp 2012). 
Caspase-1 exists in an inactive state as a zymogen, but auto-activates upon oligomerization of 
NLRP3 (Schroder and Tschopp 2012). Interestingly, adult macrophages have ASC and pro-
caspase constitutively expressed (Strowig et al. 2012). 
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Research Plan Description 
 
Inflammation is a big risk factor for developing BPD. Inflammatory cytokines are present 
in the lungs of infants that develop BPD. In addition, mouse models strongly implicate 
inflammation in abnormal lung pathology. Bacterial LPS inhibits lung development in 
chorioamnionitis and lung explant models. However, there are no studies resolving the pathway 
of events from pathogen detection to abnormal lung morphogenesis. This research focuses on the 
following questions: Which immune cells are responsible for pathogen recognition in the fetal 
lung? Are macrophages the critical immune cell required for the fetal lung to respond to 
pathogens? Can the macrophage response to pathogens be detrimental to lung development? Do 
fetal lung macrophages become polarized after pathogen detection or NF-κB detection? Does 
NF-κB activation in macrophages alter the normal macrophage population in the fetal lung? 
While the role of macrophages in the fetal lung has not been studied in depth, there are examples 
indicating their potential role. Current research has linked defective efferocyotsis, normally 
completed by macrophages, to abnormal lung development (Li et al. 2003). The possibility of 
fetal lung macrophages having many diverse functions supporting lung morphogenesis remains 
undetermined.   
The Prince laboratory first began to investigate these questions. They used multiple 
mouse models for lung explant culture and in vivo lung studies. Initially, they identified the cells 
that rapidly respond to pathogens in the fetal lung. The Prince laboratory used lung explants from 
the NGL reporter mouse to observe the first cells to activate NF-κB in response to LPS. Since 
macrophages are the initial responders to LPS, they wanted to determine if macrophages 
controlled the fetal lung inflammatory response. To do so, they used two mouse models that 
would inhibit NF-κB in macrophages, through IKKβ deletion, or would activate NF-κB in 
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macrophages, through a constitutively active IKKβ. They measured airway branching and IL-1β 
protein levels. My initial experiments in the Prince laboratory focused on characterizing the 
morphology of fetal lungs after IKKβ activation in macrophages. We found that fetal lung 
development was inhibited by NF-κB activity in macrophages.  
From this research, we were able to identify two specific questions that had previously 
been unanswered: (1) Do fetal lung macrophages have the potential to change phenotype? (2) Do 
macrophage-released proinflammatory cytokines disrupt fetal lung development? When 
macrophages were determined to be necessary and sufficient to inhibit lung development upon 
activation, we used in vitro macrophage cultures to understand the phenotype potential of fetal 
lung macrophages. As a complementary method, we used flow cytometry to identify 
subpopulations of macrophages in the fetal lung. After measuring increased levels of 
proinflammatory cytokines released after NF-κB activation in macrophages, we used 
neutralizing antibodies to proinflammatory cytokines within our in vitro lung explant models. 
We also used mouse models deleting inflammatory cytokine expression as an in vivo model. 
These projects were the basis for my research on fetal lung macrophages. 
Our research, for the first time, linked disrupted fetal lung morphogenesis to a specific 
cell type, the macrophage. Further, we were able to identify changes within the fetal lung 
macrophage that did not follow any previously described pattern of activation. We also show that 
IL-1β is the primary proinflammatory cytokine responsible for the disruption of fetal lung 
development. Future investigations into BPD can now target a specific cell type, the 
macrophage, and a specific factor, IL-1β.  
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NF-κB Signaling in Fetal Lung Macrophages Disrupts Airway Morphogenesis 
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Abstract 
 
Bronchopulmonary dysplasia is a common pulmonary complication of extreme prematurity. 
Arrested lung development leads to bronchopulmonary dysplasia, but the molecular pathways 
that cause this arrest are unclear. Lung injury and inflammation increase disease risk, but the 
cellular site of the inflammatory response and the potential role of localized inflammatory 
signaling in inhibiting lung morphogenesis are not known. In this study, we show that tissue 
macrophages present in the fetal mouse lung mediate the inflammatory response to LPS and that 
macrophage activation inhibits airway morphogenesis. Macrophage depletion or targeted 
inactivation of the NF-κB signaling pathway protected airway branching in cultured lung 
explants from the effects of LPS. Macrophages also appear to be the primary cellular site of IL-
1β production following LPS exposure. Conversely, targeted NF-κB activation in transgenic 
macrophages was sufficient to inhibit airway morphogenesis. Macrophage activation in vivo 
inhibited expression of multiple genes critical for normal lung development, leading to thickened 
	   26	  
lung interstitium, reduced airway branching, and perinatal death. We propose that fetal lung 
macrophage activation contributes to bronchopulmonary dysplasia by generating a localized 
inflammatory response that disrupts developmental signals critical for lung formation. 
 
Introduction 
 
During fetal lung morphogenesis, simple epithelial tubes develop into a complex 
structure competent for gas exchange (Warburton et al. 2000; Metzger et al. 2008). This process 
fails to occur normally in preterm infants with bronchopulmonary dysplasia (BPD), a chronic 
disease that affects ∼60% of preterm infants born before 28 wk (Stoll et al. 2010). BPD results 
from arrested airway morphogenesis during the canalicular and saccular stages of lung 
development. Normally during these stages, small terminal airways branch, expand, and divide 
to form alveolar ducts. In patients with BPD, arrested development leads to fewer saccular stage 
airways, reduced numbers of alveoli, and lower capacity for gas exchange (May et al. 2009). 
Infants born after the early saccular stage of development rarely develop BPD, suggesting that 
the canalicular and early saccular stages represent a window of disease susceptibility. Various 
environmental factors have been implicated in development of BPD, involving either airway 
epithelial injury or lung inflammation (Bhandari and Bhandari 2009, Baraldi and Filippone 
2007). Understanding how these factors lead to arrested airway morphogenesis will be critical 
for developing new therapeutic approaches. 
 
Several lines of clinical and experimental evidence suggest infection or injury leads to an 
inflammatory response that causes or exacerbates BPD. First, chorioamnionitis (infection and 
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inflammation of the amniotic membranes) is detected in up to 70% of preterm deliveries and is 
associated with increased BPD risk (Lahra et al. 2009). Second, infants that develop BPD often 
have elevated levels of inflammatory mediators in their airway both at birth and during the later 
stages of disease progression (Paananen et al. 2009; Benjamin et al. 2010). Third, 
injecting Escherichia coli LPS into the amniotic fluid of pregnant animals inhibits airway 
branching and prevents subsequent alveolar development (Prince et al. 2005; Willet et al. 2000). 
In developing an experimental mouse model for studying the mechanisms leading to BPD, we 
observed that LPS prevents saccular airway branching in both fetal mice and cultured fetal 
mouse lung explants. These data suggest innate immune activation and inflammatory signaling 
intersect with developmental pathways, interfering with processes required for branching 
morphogenesis. 
 
LPS can inhibit airway branching in fetal lung explants in the absence of circulating 
inflammatory cells (Prince et al. 2005), suggesting that resident lung cells are competent to 
transduce signals that interrupt normal lung development. We have previously identified multiple 
gene targets of inflammatory signaling that are critical for normal airway morphogenesis 
(Benjamin et al. 2010, Benjamin et al. 2009; Benjamin et al. 2007; Miller et al. 2010). However, 
the cellular site of the initial innate immune response critical for disrupting development is not 
known. Among the cell types in the fetal lung, airway epithelia and vascular endothelia appear at 
least somewhat capable of responding to microbial products (Andonegui et al. 2003, Prince et al. 
2004). To date, the potential role of macrophages in the fetal lung innate immune response has 
not been closely examined. Studies involving fetal macrophages have focused primarily on their 
ability to remove apoptotic cellular debris and remodel extracellular matrix (Henson and Hume 
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2006; Hopkinson-Woolley et al. 1994; Tomlinson et al. 2008). In this study, we report that 
macrophages are the primary cellular sites of the fetal lung innate immune response. Macrophage 
activation is required for the LPS-mediated production of inflammatory mediators that disrupt 
airway branching. In addition, targeted activation of fetal lung macrophages, both in cultured 
lung explants and developing mouse lungs in vivo, inhibits airway morphogenesis and produces 
a lung phenotype that closely resembles human BPD. Our findings indicate that macrophage 
activation and subsequent lung inflammation may play a key role in BPD pathogenesis. 
 
Methods and Materials 
 
Reagents 
Gel-purified E. coli LPS (O55:B5) was purchased from Sigma-Aldrich. The following Abs were 
used for immunolabeling: rat anti-CD68 (Acris), rat anti-F4/80 (Acris), rat anti–E-cadherin 
(Zymed), rabbit anti-CD14 (Santa Cruz Biotechnology), and rabbit anti-GFP (Abcam). DAPI, 
TO-PRO-3 iodide, ProLong Gold antifade reagent with DAPI, and Alexa-conjugated secondary 
Abs were purchased from Invitrogen. Anti-CD11b Microbeads and magnetic separation 
equipment and reagents were purchased from Miltenyi Biotec. Reagents for preparing liposomal 
clodronate were obtained from Sigma-Aldrich. All cell culture media were purchased from 
Invitrogen. FBS was purchased from Thermo Fisher Scientific. 
 
 
Mouse strains and lung explant culture 
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All animal experiments were thoroughly reviewed and approved by the Vanderbilt University 
Institutional Animal Care and Use Committee. BALB/cJ and Rosa26-YFP mice were obtained 
from The Jackson Laboratory. NGL (Everhart et al. 2006), LysM-Cre:IKKβF/F (Greten et al. 
2004), and IKFM (L. Connelly, W. Barham, H.M. Onishko, L. Chen, T. Sherrill, T. Zabuawala, 
M.C. Ostrowski, T.S. Blackwell, and F.E. Yull, submitted for publication) mouse strains were 
developed and described previously. For timed pregnant matings, embryonal day 0 (E0) was 
defined as the morning of vaginal plug discovery. To induce transgene expression in IKFM mice, 
timed pregnant dams were given doxycycline-containing water (2 g/L) ad libitum. E15 fetal 
mouse lung explants were isolated and cultured as previously described (Prince et al. 2004). For 
transgenic models, lungs of each mouse embryo were minced and cultured separately. 
Approximately 20 explants were isolated from each embryo. All explants studied were between 
0.8 and 1.2 mm in diameter at initial time of culture. To quantify saccular airway branching in 
cultured lung explants, brightfield images of explants were acquired every 24 h of culture. 
Airway branching was expressed as the number of new branches that formed between 24 and 72 
h of culture in each explant. For macrophage depletion using clodronate, control or clondronate-
containing liposomes were directly added to explants at the initial time of isolation. LPS was 
then added to the media 24 h later. 
 
Fetal lung macrophage isolation 
E15 fetal mouse lungs were dissected free of surrounding tissues and placed in ice-cold PBS. 
The lungs were homogenized and forced through 100-μm and 40-μm cell strainers. Cells were 
pelleted by centrifugation and resuspended in the presence of anti-CD11b–conjugated 
Microbeads (Miltenyi Biotec). The CD11b-labeled cells were collected using a magnetic 
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separator, washed, and plated in RPMI 1640 with 10% FBS. Following overnight culture at 37°C 
in 95% air/5% CO2, macrophages were washed and treated for 4 h with LPS (250 ng/ml). NGL 
macrophages were similarly isolated, treated with LPS for various time points, and solubilized in 
Reporter Lysis Buffer (Promega). Luciferase activity was measured using SteadyGlo reagent 
(Promega) and a Synergy HT microplate reader (Biotek). Luciferase activity was normalized to 
total protein content as measured by BCA assay (Promega). 
 
RNA isolation, real-time PCR, and IL-1β  measurement 
Total RNA isolation, cDNA synthesis, and real-time PCR were performed using standard 
techniques. Gene expression was compared using the 2−ΔΔCT method. Independent experiments 
were performed at least three separate times. Data between groups were compared by ANOVA 
or Student t test to test for significant differences. IL-1β concentrations were measured in 
homogenized fetal lung using the Quantikine Mouse IL-1β Immunoassay (R&D Systems). IL-1β 
concentrations were normalized to total protein as measured by BCA assay (Pierce). 
 
Tissue Processing and Immunolabeling 
Mouse lung tissue, fetal lung explants, and cultured macrophages were fixed, processed, and 
immunolabeled using standard techniques. For immunofluorescence, Alexa-conjugated 
secondary Abs were used for visualization, and nuclei were alternatively labeled with DAPI or 
TO-PRO-3. Immunohistochemical processing was performed using Vectastain Kits and 3,3′-
diaminobenzidine visualization (Vector Laboratories) with Mayer’s H&E counterstaining 
(Sigma-Aldrich). 
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Imaging and image analysis 
Confocal images were acquired using either an Olympus FV1000 (Olympus) or Leica SPE 
(Leica Microsystems) laser scanning confocal microscope. Widefield fluorescence images and 
brightfield images of fetal mouse lung explants were obtained using an Olympus IX81 
microscope equipped with a Hamamatsu Orca ER CCD monochrome camera and Slidebook 
software (Olympus). Color images of lung specimens were photographed using a Nikon TE800 
and SPOT color CCD camera (Diagnostic Instruments). All microscopy images were saved in 
the Tagged Image File format and imported into Photoshop (Adobe Systems) for processing. 
Images for comparison were always identically processed. For live imaging of NF-κB activation, 
NGL explants were cultured in a stage-top incubator (Okolab) and imaged using an Olympus 
IX81 inverted microscope (Olympus) with a WeatherStation enclosure. Exact temperature, 
humidity, and CO2 concentration were maintained during the imaging experiment. Fluorescence 
images were acquired every 10 min for the first 2 h and then every 20 min for 2–24 h of culture. 
Time series images were processed in Slidebook (Olympus). Lung morphometery and cell 
counting were performed using the Image Processing Tool Kit (Reindeer Graphics) within 
Photoshop (Adobe Systems). Fractional lung volumes were measured by analyzing images from 
serial fetal lung sections using a counting grid function. The fractions of airspace, large airway 
epithelia, small or distal airway epithelia, and mesenchyme were measured on E-cadherin–
labeled sections. Septal thickness in newborn lungs was measured using the global intercept 
function. To account for possible anisotropy, intercepts in each image were measured over 
multiple iterations with 10° of rotation between each measurement. The mean intercept length 
for each image was recorded. 
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Results 
 
LPS activates NF-κB in fetal lung macrophages 
Where LPS initially activates the innate immune system in fetal lungs has not been 
identified. We therefore investigated the localization and kinetics of LPS-induced NF-κB 
activation in E15 fetal lung explants from NF-κB transgenic reporter mouse (NGL), which 
expresses GFP and luciferase downstream of a promoter synthesized from the NF-κB–binding 
repeats within the HIV-1 long terminal repeat (Everhart et al. 2006). Time-lapse imaging of NGL 
explants demonstrated NF-κB–dependent GFP expression by 90 min after LPS treatment, with 
continued GFP expression to 12 h (Fig. 2.1A–D). GFP expression localized to cells throughout 
the lung mesenchyme. To visualize the cellular site of NF-κB–GFP expression at higher 
resolution, we imaged NGL explants using confocal microscopy. As seen in Fig. 2.1E–M, 2 h of 
LPS treatment stimulated GFP expression predominantly in cells that colabeled with the 
macrophage marker CD68. Following 12 h of LPS treatment, GFP reporter expression was 
detected both in CD68-positive macrophages and in adjacent mesenchymal cells (arrows in Fig. 
2.1G, 2.1M). The close proximity of GFP-expressing mesenchymal cells to CD68-postive 
macrophages suggests release of secondary inflammatory mediators that could then activate NF-
κB in nearby cells. 
 
 Because macrophages were present in E15 fetal lungs and positioned to regulate 
inflammatory responses, we examined the timing of macrophage appearance into the fetal mouse  
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Figure 2.1. LPS stimulates NF-κB–dependent GFP expression in NGL fetal mouse lung 
explants. E15 fetal lung explants from NGL mice were cultured under control conditions (A, C) 
or in the presence of LPS (B, D) and imaged by time-lapse wide field fluorescence microscopy. 
Increased GFP expression was detected within 90 min of LPS treatment (B) and persisted beyond 
12 h (D). Scale bar, 100 μm (A–D). Confocal images of control and LPS-treated NGL explants 
were obtained to better identify sites of GFP expression (E–M). Explants were fixed and 
immunostained for CD68 (red, H–M) following 2 and 12 h of LPS treatment. Nuclei were 
labeled with DAPI. In LPS-treated explants, NF-κB–GFP expression colocalized with CD68-
postive macrophages following LPS treatment (GFP green, E–G; CD68 and GFP merged image 
in K–M). At 12 h, GFP expression was also detected in CD68-negative cells (arrows, G, M). 
Saccular airways are indicated by dotted lines. Scale bar, 25 μm (E–M). 
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lung during development. Immunostaining identified CD68-positive cells in the lung 
mesenchyme as early as E10 during the initial steps of lung formation (Fig. 2.2A). Macrophages  
 
remained present in the mesenchyme throughout fetal development. Fetal lung macrophages also 
expressed F4/80 (Fig. 2.2B). To measure function, we tested if LPS could directly activate 
isolated fetal lung macrophages. We obtained macrophages from E15 lungs using anti-CD11b–
coated magnetic beads (Fig. 2.2C), exposed them to E. coli LPS, and measured gene expression 
by RT-PCR. LPS stimulated macrophage expression of the inflammatory mediators IL-1β and 
TNF-α, but did not affect expression of TGF-β or BMP4 (Fig. 2.2D). Using macrophages 
isolated from E15 NGL mouse lungs, we next showed that LPS directly activates NF-κB–
dependent luciferase activity (Fig. 2.2E). These data clearly demonstrate that macrophages 
within the fetal mouse lung respond to LPS and can produce inflammatory mediators. 
 
Macrophage activation inhibits saccular airway branching 
We have previously developed an E15 fetal mouse lung explant model to study the mechanisms 
regulating canalicular and saccular stage airway branching (Prince et al. 2005; Prince et al. 
2004). Following 72 h of culture, the structures along the periphery of these explants resemble 
early saccular lungs by undergoing type I/type II cell differentiation, thinning of the 
mesenchyme, and branching of small airways. This model parallels the period of lung 
development occurring postnatally in extremely preterm infants born between 23 and 28 wk 
gestation, making it relevant for investigating BPD pathogenesis. Airway branching in E15 
explants requires fibronectin, mesenchymal α8β1-integrin expression, and fibroblast growth 
factor-10 (FGF-10) (Prince et al. 2005; Benjamin et al. 2009; Benjamin et al. 2007). We have 
also previously shown that TLR agonists, hyperoxia exposure, and  
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Figure 2.2. Macrophages are present in the fetal mouse lung and respond to LPS. A, Frozen 
sections of E10–E18 fetal mouse lungs were immunostained with Abs against the macrophage 
marker CD68 (green) and the epithelial marker E-cadherin (red). Nuclei were labeled with 
DAPI. Scale bar, 50 μm. B, Macrophages from E15 lung also express F4/80 (green). Scale bar, 
50 μm. C, Fetal lung macrophages isolated by anti-CD11b magnetic bead separation from E15 
lungs expressed CD68 (green). Scale bar, 50 μm. D, Macrophages were treated with E. coli LPS 
for 4 h, and gene expression was measured by RT-PCR. LPS increased IL-1β and TNF-α 
expression, but had no effect on TGF-β or BMP4. E, LPS activates NF-κB in E15 fetal mouse 
lung macrophages. Macrophages isolated from E15 NGL lungs were treated with LPS for the 
indicated times. NF-κB–luciferase was measured by luminometry. *p < 0.05; n = 6. 
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tracheal aspirate fluid from preterm infants exposed to antenatal inflammation can each inhibit 
airway branching in cultured explants (Prince et al. 2005; Benjamin et al. 2007; Dieperink et al. 
2006). To initially test if the inhibitory effects of LPS on branching required macrophage 
activation, we depleted macrophages from E15 fetal lung explants using clodronate-containing 
liposomes (Fig. 2.3). We then measured the number of new airways that formed along the 
periphery of each explant between 24 h and 72 h. Although LPS inhibited formation of new 
saccular airways in control and empty liposome-treated explants (Fig. 2.3E, 2.3G), clodronate 
depletion of macrophages protected saccular airway branching from the effects of LPS (Fig. 
2.3F, 2.3G). Macrophage depletion also substantially reduced the amount of LPS-induced IL-1β 
within lung explants (Fig. 2.3H), suggesting macrophages produce most of the IL-1β within 
LPS-treated fetal lung explants. Macrophages, therefore, are important for both production of 
inflammatory mediators within the fetal lung and inhibiting airway branching following 
exposure to LPS. 
  
 As clodronate could have off-target toxic effects, we next used a molecular approach to 
test if NF-κB activation in macrophages was required for LPS-dependent disruption of saccular 
airway branching. For these experiments, we used mice with macrophage-specific IκB kinase β 
(IKKβ) deletion. LysM-Cre:IKKβf/f mice (IKKβΔ) lack functional IKKβ in myeloid cells, 
including macrophages and monocytes (Greten et al. 2004). LysM-Cre recombinase activity was 
confirmed in fetal lung explant macrophages using Rosa26-YFP reporter mice (Fig. 2.4A, 2.4B). 
We next measured the effects of LPS on explants from IKKβΔ and littermate controls. LPS 
failed to inhibit saccular airway branching in IKKβΔ explants (Fig. 2.4C, 2.4D), supporting the 
critical role of macrophages in inflammation-dependent disruption of airway  
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Figure 2.3. Macrophage depletion protects fetal lung explants from the effects of LPS. A andB, 
E15 fetal mouse lung explants were cultured in the absence or presence of liposomal clodronate 
(50 mg/ml). Following 72 h of culture, explants were immunostained with Abs against the 
macrophage marker CD68 to verify macrophage depletion (B). C–F, Brightfield images show 
that LPS inhibits formation of new saccular airway branches (E), but this effect is prevented in 
clodronate-treated explants (F). Scale bar, 50 μm (A–F). G, LPS inhibited formation of new 
saccular airways in control and empty liposome-treated explants (*p < 0.001; n = 24). However, 
LPS did not inhibit branching in clodronate-treated explants. H, Clodronate depletion of 
macrophages reduced the amount of IL-1β released following LPS treatment (*p < 0.05 LPS 
compared with untreated [n = 4],#p < 0.01 LPS compared with LPS + clodronate [n = 4]). 
 
  
	   38	  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.4. Targeted deletion of IKKβ in macrophages protects fetal lung explants from the 
effects of LPS. A, LysM-Cre recombinase activity in E15 fetal mouse lung explants. 
Fluorescence images of cultured LysM-Cre:Rosa26-YFP reporter explants. YFP expression is 
seen in macrophages throughout the explant. Cell nuclei visualized with DAPI. Scale bar, 50 
μm. B, LysM-Cre:Rosa26-YFP macrophages immunostained with Ab against CD68 (red) to 
show overlapping expression. Scale bar, 10 μm. C, LPS does not inhibit saccular airway 
branching in IKKβΔ explants. Scale bar, 50 μm. D, LPS inhibited the number of new saccular 
airways that formed between 24 and 72 h of culture in IKKβF/+ and wild-type BALB/cJ (WT) 
explants, but had no effect on branching in IKKβΔ explants (*p < 0.05; n = 28). E, Macrophage 
expression of IKKβ is required for normal IL-1β expression following LPS treatment. LPS 
increased IL-1β production in littermate control IKKβF/+explants (*p < 0.05; n = 6), but did not 
significantly increase IL-1β in IKKβΔ explants (#p < 0.05 compared with LPS in 
IKKβF/+ explants; n = 6). 
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morphogenesis and identifying NF-κB as the operative signaling pathway in mediating this 
effect. The total amount of IL-1β produced in LPS-treated IKKβΔ explants was much lower than 
in explants from littermate controls, again demonstrating that macrophages are responsible for a 
majority of the IL-1β produced in the LPS-treated fetal lung (Fig. 2.4E). 
 
 Having observed that activation of the NF-κB pathway in macrophages appears to 
mediate the effects of LPS on saccular airway morphogenesis, we next tested if NF-κB 
activation in macrophages is sufficient to disrupt airway morphogenesis and whether 
macrophages can impact airway formation in vivo. For these experiments, we used IKFM 
transgenic mice that express a macrophage-specific doxycycline-inducible c-fms transactivator 
and a constitutively active IKKβ mutant (cIKKβ) gene downstream of a tet-responsive promoter 
(L. Connelly et al., submitted for publication). We cultured saccular stage fetal lung explants 
from IKFM mice and control littermates in the absence or presence of doxycycline (Fig. 2.5A, 
2.5B). Doxycycline had no effect on branching in control explants, but caused airway dilation 
and reduced branch formation in IKFM explants (Fig. 2.5B). Excessive IKKβ activity in IKFM 
macrophages inhibited branching, as did adding LPS (Fig. 2.5C). Inducing cIKKβ expression in 
macrophages increased IL-1β expression in fetal lung explants, demonstrating activity of the 
transgene (Fig. 2.5D). These results suggest that NF-κB activation specifically in macrophages is 
sufficient to disrupt normal fetal lung morphogenesis. 
 
Targeted NF-κB activation in mouse macrophages disrupts lung morphogenesis 
We next tested if macrophage-specific overexpression of cIKKβ in IKFM mice could 
alter lung morphogenesis in intact fetal mice. Pregnant IKFM mice were treated with  
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Figure 2.5. IKKβ activity in macrophages is sufficient to inhibit saccular airway branching. 
Brightfield images of E15 fetal lung explants from IKFM mice (B) and littermate controls (A) 
cultured under control conditions (top panels), in the presence of doxycycline (middle panels), 
and in the presence of LPS (bottom panels). Scale bar, 50 μm (A, B). C, Doxycycline induction if 
cIKKβ in macrophages inhibited saccular airway branching. Doxycycline had no effect in 
littermate control explants, whereas LPS inhibited formation of new saccular airway branches in 
both control and IKFM explants (*p < 0.05 compared with branches formed in the absence of 
doxycycline and without LPS [n = 9], #p < 0.05 compared with IKFM explants in the absence of 
doxycycline and without LPS [n = 9]). D, Doxycycline induction of cIKKβ in macrophages 
increased IL-1β expression in IKFM explants (*p < 0.05; n = 9). Dotted line indicates baseline 
expression level. E, Overexpression of cIKKβ in macrophages inhibits saccular stage lung 
morphogenesis in vivo. IKFM mice were given doxycycline (Dox) from either E12–E16 (top 
panels) or E14–E18 (bottom panels). Sections were immunostained using anti–E-cadherin to 
label epithelia. Scale bars, 100 μm. Lung morphogenesis did not appear altered in mice given 
Dox from E12–E16, either by histology or morphometric measurement of large and small airway 
epithelia, airspace (air), and mesenchymal (mes.) volumes (F). Dox administration from E14–
E18 disrupted normal lung development, with IKFM lungs having smaller airways with reduced 
branching and expansion (E, G). Morphometry measurements confirmed decreased airspace and  
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increased mesenchymal volumes in IKFM mice treated with Dox (G; *p < 0.001; n = 27). 	  
doxycycline to activate macrophages during either the late pseudoglandular stage (E12–E16) or 
from the late pseudoglandular stage through the canalicular and early saccular stages (E14-
E18, Fig. 2.5E). Doxycycline administration from E12–E16 did not cause apparent changes in 
airway formation (Fig. 2.5E, 2.5F). However, transgene activation from E14–E18 caused 
significant changes with less airspace and increased mesenchyme in IKFM lungs compared with 
littermate controls (Fig. 2.5E, 2.5G). These differences were consistent with defects in saccular 
airway branching morphogenesis. The lack of effect in mice treated E12–E16 suggests that 
airway branching in the E14–E18 lung may have a window of vulnerability to macrophage 
activation. These data support the idea that macrophage activation and subsequent lung 
inflammation disrupt the later stages of airway formation. 
 
To investigate how the morphological changes observed in IKFM mice affect respiratory 
function, mice treated with doxycycline from E14–E18 were allowed to deliver at E19 and E20. 
Disruption of normal lung development in IKFM pups led to reduced survival in the first 24 h. 
Newborn IKFM mice appeared cyanotic, and many died soon after birth, whereas control 
littermates appeared healthy (Fig. 2.6A, 2.6B). Histological examination of newborn IKFM lungs 
again showed a thickened lung interstitium compared with control littermates (Fig. 2.6C, 2.6D). 
As with mice harvested at E18, the microscopic appearance of newborn IKFM mouse lungs, with 
thickened interstitium and simplified airways, showed similarities to the lungs of patients with 
BPD. Macrophages were present both lining the airway lumen and within the interstitium in both 
control and IKFM newborn lungs (Fig. 2.6E). IKFM mice had increased numbers of F4/80-
positive cells, which may represent increased macrophage recruitment, maturation, or  
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Figure 2.6. Targeted expression of a cIKKβ in fetal macrophages causes arrested lung 
development and perinatal lethality. A and B, Pregnant mice were treated with doxycycline from 
E14–E18 and then allowed to deliver. Newborn IKFM mice were born alive but developed 
respiratory distress and became cyanotic and lethargic soon after delivery. Littermate controls 
appeared healthy and vigorous. C and D, Newborn IKFM lungs have abnormal structure, with 
wider interstitium between airways and increased mean septal thickness (*p < 0.01; ν = 15). 
Scale bar, 100 μm (C, D). E and F, Immunostaining for F4/80 shows increased numbers of 
macrophages in newborn IKFM lungs compared with control littermates. Scale bar, 100 μm 
(E, F). G, The numbers of lymphocytes and neutrophils (PMN) in the lungs of newborn IKFM 
mice and littermate controls were similar. H, Reduced expression of genes required for normal 
branching morphogenesis in newborn IKFM lungs treated from E14–E18 with doxycycline. 
Expression measured by real-time PCR (*p < 0.05; n = 7). Dotted line indicates control 
expression level. 
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proliferation (Fig. 2.6F). IKFM and control lungs contained similar numbers of lymphocytes and 
neutrophils (Fig. 2.6G), without signs of consolidated infiltrates or edema. These data further  
demonstrate that macrophage NF-κB activation, which could occur secondary to infection or 
other insults, can inhibit saccular airway morphogenesis. 
 
Macrophage activation from E14–E18 in IKFM mice caused a persistent inhibition of 
expression of multiple genes critical for branching morphogenesis in newborn lungs (Benjamin 
et al. 2009; Weaver et al. 2000; Rajagopal et al. 2008), including reduced expression of the 
α8 integrin subunit, BMP4, and Wnt7b (Fig. 2.6H). Expression of BMPR1A and FGF-10 also 
trended lower in IKFM lungs. Macrophage activation and release of inflammatory cytokines can 
therefore inhibit gene expression in the developing lung, leading to altered airway 
morphogenesis. These findings are consistent with our findings in lung explants, where 
macrophage activation can inhibit airway branching in the absence of systemic circulation. 
Activation of NF-κB in fetal lung macrophages could therefore be a common feature of insults 
that disrupt normal airway morphogenesis. As such, our model of a BPD-like phenotype in 
IKFM mice may be useful in further defining the pathogenesis and course of BPD. 
 
Discussion 
 
In this study, we demonstrate that NF-κB activation in macrophages is a key initial step 
in the fetal lung inflammatory response and sufficient to disrupt fetal lung morphogenesis. 
Macrophages in the canalicular or saccular stage fetal lung reside in the interstitium and respond 
to endotoxin. The NF-κB–dependent release of inflammatory mediators from these activated 
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macrophages may then cause a second wave of signaling in neighboring cells, including the 
mesenchymal cells critical for airway morphogenesis. Even when the entire fetal lung is exposed 
to LPS, as is the case when explants are treated with LPS, macrophages appear to be the major 
cellular site of NF-κB activation and cytokine production. Macrophage depletion or targeted 
IKKβ deletion dramatically reduced the amount of IL-1β produced in response to LPS treatment 
and protected airway branching from the inhibitory effects of LPS. In addition, targeted 
activation of fetal lung macrophages was sufficient to disrupt lung morphogenesis, causing 
perinatal lethality and airway pathology that resembles human BPD. 
 
These findings fill an important gap in our knowledge of how the immature fetal lung 
responds to inflammatory stimuli. When preterm infants are exposed to chorioamnionitis in 
utero, inflammatory cytokines accumulate in their airways (Benjamin et al. 2010). The infants 
with high levels of inflammatory mediators in their lungs at birth are more likely to develop BPD 
(Choi et al. 2006). Not only are macrophages the major source of inflammatory mediators in the 
lung, but also their location in the fetal lung interstitium may increase the likelihood that 
macrophage-derived cytokines can affect immediately adjacent cells. Recent studies have 
demonstrated increased macrophage recruitment to fetal or newborn lungs following either 
mechanical or endotoxin-mediated injury (Hillman et al. 2011; Cao et al. 2009). However, our 
current study is the first to connect macrophage activation and altered lung morphogenesis, to 
our knowledge. We propose a two-wave mechanism for NF-κB activation leading to arrested 
lung development in BPD. In this model, microbial products initially activate NF-κB in lung 
macrophages. The release of inflammatory mediators, particularly IL-1β and/or TNF-α, then 
causes NF-κB activation in the adjacent mesenchymal cells. NF-κB activation in the 
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mesenchyme disrupts expression of genes important for the precise, controlled epithelial–
mesenchymal interactions that regulate airway branching. This mechanism is supported by our 
previous findings that NF-κB activation in fetal lung mesenchymal cells interferes with normal 
expression of important developmental genes, including FGF-10 and integrin α8β1 (Benjamin et 
al. 2010; Benjamin et al. 2009; Benjamin et al. 2007; Miller et al. 2010). The decreased BMP4 
expression in IKFM lungs may be due to the direct effect of inflammatory cytokines on the 
airway epithelium (Zhu et al. 2007) or secondary to reduced FGF-10 expression in the 
mesenchyme (Weaver et al. 2000). Although inflammatory mediators that signal via other 
pathways may also affect lung development, those that can activate NF-κB in target cells appear 
to be most detrimental. 
 
The IFKM mouse strain may provide an important model for further studying how 
macrophage activation and inflammation arrests lung development, particularly if the phenotype 
can be modulated so that affected pups can survive the neonatal period. The inducible cIKKβ 
transgene allows macrophage activation at distinct stages of lung development, as compared with 
postnatal rodent models that are restricted to studying the late saccular and alveolar stages of 
lung development (McGrath-Morrow and Stahl 2001). Human infants born at a comparable stage 
of lung development to that of newborn mice very rarely develop BPD, making these 
experimental models less useful for investigating the early mechanisms of BPD pathogenesis 
(Stoll et al. 2010). IKFM mice may also allow us to test if the effects of macrophage activation 
are reversible or persistent, how repetitive activations affect lung development, and if 
macrophage activation alters the susceptibility to other types of injury including hyperoxia, 
mechanical trauma, and viral infection. These future studies may help us better understand why 
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some infants develop only mild BPD and others have more severe or progressive disease. The 
IKFM experimental model will potentially permit studies that target different phases of the 
inflammatory response in the fetal and newborn lung to better identify potential strategies for 
treatment. 
 
Although fetal lung macrophages clearly respond to innate immune stimuli, their 
functional role in normal embryogenesis remains uncertain. In developing tissues, macrophages 
may remove cellular debris, remodel extracellular matrix, or express growth factors 
(Ovchinnikov 2008). Removal of apoptotic cells may be critical for lung morphogenesis, as at 
least one study has demonstrated that mice lacking the phosphoserine receptor are unable to 
phagocytose apoptotic cells and die following birth with abnormal lung structure (Li et al. 2003). 
In the developing mammary gland, macrophages localize to collagen fibrils along elongating 
ductal branches, possibly playing a role in extracellular matrix remodeling (Ingman et al. 2006). 
Macrophages present in the fetal kidney may contribute to development by expressing specific 
Wnt ligands (Lin et al. 2010). We do not yet know if fetal lung macrophages play a similar 
trophic role in normal airway morphogenesis. In addition to the downstream effects of 
macrophage-derived cytokines on mesenchymal cell gene expression, inflammatory activation 
could divert macrophages from their yet uncharacterized developmental or trophic roles. This 
intersection of inflammatory and developmental pathways could therefore be a focal point for 
disease pathogenesis. 
 
The two-wave model for propagation of inflammatory signals that disrupt branching 
morphogenesis suggests several potential therapeutic strategies for preventing BPD. Targeting 
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macrophage activation could prevent the initial wave of fetal lung inflammation. The feasibility 
of this approach is supported by our experimental data using macrophage depletion and targeted 
deletion of IKKβ. However, many women clinically present already in preterm labor and with 
evidence of chorioamnionitis (Romero et al. 2007). In these situations, fetal lung macrophage 
activation may have occurred prior to delivery. Therefore, alternative strategies could target 
inflammatory mediators such as IL-1β and TNF-α to prevent the effects of inflammation on 
mesenchymal gene expression and altered epithelial–mesenchymal interactions. Finally, 
approaches that restore the mesenchymal cell phenotype to a normal fetal lung gene expression 
pattern and cell behavior could promote ongoing lung morphogenesis even in preterm infants 
with previous inflammatory exposures. 
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IκB Kinase Activity Drives Fetal Lung Macrophage Maturation along a  
Non-M1/M2 Paradigm 
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Abstract 
 
 In preterm infants, exposure to inflammation increases the risk of bronchopulmonary 
dysplasia, a chronic, developmental lung disease. While macrophages are the key cells that 
initiate lung inflammation, less is known about lung macrophage phenotype and maturation. We 
hypothesized that fetal lung macrophages mature into distinct subpopulations during mouse 
development, and that activation could influence macrophage maturation. Expression of the fetal 
macrophage markers CD68, CD86, CD206, Ym1, fibrinogen-like protein 2 (FGL2), and 
indolamine-2, 3-dioxygenase (Ido1) were developmentally regulated, with each marker having 
different temporal patterns. Flow cytometry analysis showed macrophages within the fetal lung 
were less diverse than the distinctly separate subpopulations in newborn and adult lungs. Similar 
to adult alveolar macrophages, fetal lung macrophages responded to the TLR4 agonist LPS and 
the alternative activation cytokines IL-4 and IL-13. Using a macrophage-specific constitutively 
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active IKKβ transgenic model (IKFM), we demonstrated that macrophage activation increased 
proinflammatory gene expression and reduced the response of fetal lung macrophages to IL-4 
and IL-13. Activation also increased fetal lung macrophage proliferation. Fetal IKFM lungs 
contained increased percentages of more mature, CD11bloF4/80hi cells that also expressed higher 
levels of the alternative activation markers CD204 and CD206. Development of fetal lung 
macrophages into mature alveolar macrophages may therefore include features of both 
proinflammatory and alternative activation paradigms. 
 
Introduction 
 
To maintain efficient gas exchange between the airspace and pulmonary circulation, the 
alveolar environment must remain dry, sterile, and free of particulates. As part of the lung innate 
immune system, macrophages protect the lung from inhaled pathogens, microbes, and harmful 
particulates. Within the alveolar environment, macrophages are the primary cells that kill 
pathogens and remove cellular and foreign debris. Expressing an array of pattern recognition 
receptors on their cell surface, lung macrophages detect and engulf inhaled microbes (Gordon 
and Taylor, 2005). Macrophages phagocytose and kill these pathogens by producing 
antimicrobial reactive oxygen and nitrogen species (Fang, 2004). When unable to completely kill 
and remove microbial pathogens, macrophages secrete cytokines and chemokines that recruit 
additional inflammatory cells to the alveolar space (Gutierrez-Ramos et al. 2000). Macrophages 
then remove both host and microbial cellular debris and promote tissue repair (Mosser and 
Edwards, 2008).  
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Like other tissues, the mature lung contains multiple macrophage subpopulations (Laskin 
et al. 2001). These groups of macrophages appear to differ in their origin, phenotypic marker 
expression, and functional role in the immune response. During development, macrophages first 
originate in the yolk sac and later from hematopoietic precursors in the fetal liver (Yona et al. 
2013; Geissmann et al. 2010). Cells from both sources populate the lung, with additional bone 
marrow-derived monocytes migrating to the lung and differentiating into macrophages 
(Geissmann et al. 2010; Schulz et al. 2012). In addition, proliferation of differentiated cells can 
sustain macrophage populations within tissues (Yona et al. 2013). In addition to potentially 
deriving from different macrophage sources, the various macrophage subpopulations may have 
distinct functional roles. 
 
Proinflammatory macrophages respond robustly to microbial organisms by 
phagocytosing infectious particles and releasing soluble inflammatory mediators (Sica and 
Mantovani 2012). In addition to sensing extracellular microbes, infection of proinflammatory 
macrophages by intracellular pathogens elicits inflammatory cytokine and chemokine release 
(Ghisletti et al. 2010). Also referred to as M1 or classically activated macrophages, these 
proinflammatory cells typically express the surface marker CD86 and cytokines IL-1β and 
TNFα (Ghisletti et al. 2010). TLR agonists, microbial products, and IFN-γ activate 
proinflammatory macrophages in slightly different ways, giving diversity to the inflammatory 
response (Sica and Mantovani 2012; Xue et al. 2014). In comparison, macrophages with an 
alternative phenotype can be classified as M2a, M2b, M2c, or M2d (Mantovani et al. 2004; 
Duluc et al. 2007). These alternatively activated or M2 macrophages express FGL2, Ym1, and 
the scavenger receptors CD204 and CD206 (Mantovani et al. 2013; Martinez et al. 2006; Ruffell 
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et al. 2012). Alternatively activated cells are induced by IL-4 and IL-13 (M2a), TLR or IL1R 
ligands (M2b), IL-10 (M2c), or the tumor microenvironment (M2d) (Mantovani, Sica et al. 2004; 
Duluc et al. 2007; Gordon and Martinez 2010).  M2 macrophages play roles in parasitic 
infections (M2a), atopic allergic disorders (M2a), Th2 differentiation (M2b), wound healing 
(M2c), and tumor progression (M2d) (Mantovani et al. 2004; Duluc et al. 2007). The relative 
differences and unique properties of M1/M2 macrophages have been investigated in cancer, 
diabetes, and chronic inflammatory disease (Ruffell et al. 2012; Lumeng et al. 2007; Sindrilaru et 
al. 2011; Red Eagle and Chawla 2010; Cortez-Retamozo et al. 2013). How this M1/M2 paradigm 
applies to lung macrophages during both normal lung homeostasis and in disease processes is not 
completely clear. 
 
Macrophages play important roles in both neonatal and adult lung immunity. However, 
neonatal lung macrophages, especially those found in preterm infants, may lack fully mature 
innate immune function. Neonates are particularly susceptible to pneumonia and inhaled 
pathogens, suggesting either immature killing or inability to control localized lung inflammation 
(Kollmann, Levy et al. 2012). Previous studies showed that neonatal monocytes responded 
normally to TLR agonists to produce inflammatory cytokines IL-6 and TNFα, but macrophages 
from preterm infants have reduced IL-10 release (Blahnik et al. 2001; Angelone et al. 2006; 
Yerkovich et al. 2007). Recent studies reported an increase in M2 markers in the postnatal mouse 
lung (Jones et al. 2013). However, detailed characterization of fetal macrophages, how they 
respond functionally to proinflammatory and alternative activation stimuli, and the 
developmental signaling pathways regulating maturation are not understood. 
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Lung inflammation plays a key role in the pathogenesis of bronchopulmonary dysplasia 
(BPD) in preterm infants (Watterberg et al. 1996). Patients with elevated proinflammatory 
cytokines in their lungs are more likely to have arrested lung development and develop chronic 
lung disease (Tullus et al. 1996; Baier et al. 2001; Wang et al. 2002). Macrophages are the 
primary cellular sources of these soluble inflammatory mediators in the lung. We demonstrated 
in mice that macrophage activation was required and sufficient for microbial products to cause 
arrested airway and alveolar morphogenesis (Blackwell et al. 2011). Targeted NF-κB activation 
in fetal macrophages disrupted normal developmental gene expression in epithelial and 
mesenchymal cells and led to perinatal lethality (Blackwell et al. 2011). Interestingly, this 
disruption of lung morphogenesis occurred only during later stages of development, suggesting 
macrophage maturation might also be playing a role in the connections between lung 
inflammation and development.  
 
We hypothesized that macrophages undergo significant maturational changes during fetal 
lung development, with mature macrophages having either a predominantly proinflammatory 
(M1) or alternative (M2) phenotype.  We therefore measured expression of multiple macrophage 
markers across fetal mouse lung development. Transcriptional responses to LPS and IL-4/IL-13 
in fetal and adult lung macrophages tested the effects of macrophage activation on maturation. 
The changes we observed both with normal development and following activation did not fit 
neatly within an M1/M2 paradigm, but instead demonstrated unique mixed phenotypes in lung 
macrophage populations. These data will be essential for future studies examining macrophage 
differentiation and function in neonatal and pediatric inflammatory lung diseases. 
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Materials and Methods 
 
Reagents 
The following antibodies were used for immunofluorescence: rat anti-CD68 (Acris), rabbit anti-
CD86 (Abcam), rat anti-Ym1 (R&D Systems), rabbit anti-CD206 (Abcam), goat anti-
macrophage galactose N-acetyl-galactosamine specific lectin (Mgl1/2, R&D Systems), rat anti-
Ecadherin (Zymed), mouse anti-alpha-smooth muscle actin-Cy3 (α-SMA, Sigma-Aldrich), 
rabbit anti-Ki67 (Abcam). ProLong Gold with DAPI mounting media and Alexa-conjugated 
secondary antibodies were purchased from Invitrogen. DRAQ5 (1,5-bis{[2-(di-methylamino) 
ethyl]amino}-4, 8-dihydroxyanthracene-9,10-dione) was purchased from Biostatus Limited. 
Anti-CD11b microbeads and magnetic separation equipment were obtained from Miltenyi 
Biotec. Gel-purified Escherichia coli LPS (O55:B5), deoxyribonuclease I from bovine pancreas 
Type IV (DNase), and collagenase from clostridium histolyticum, Type XI were obtained from 
Sigma-Aldrich. Recombinant mouse IL-4 and IL-13 were purchased from R&D Systems. RPMI 
1640 media was purchased from Invitrogen, and FBS was purchased from Thermo Fisher 
Scientific. 
 
Mouse strains 
The Institutional Animal Care and Use Committees from Vanderbilt University and the 
University of California at San Diego approved all animal experiments. C57Bl/6 mice were 
obtained from Harlan Laboratories. For transgenic expression of enhanced green fluorescent 
protein (EGFP) in macrophages, we used C57BL/6J-Tg(Csf1r-EGFP-
NGFR/FKBP1A/TNFRSF6)2Bck/J mice from the Jackson Laboratory. These mice express 
EGFP downstream of the Csf1r promoter and have no obvious phenotype in the absence of 
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FKBP dimerization agents (Burnett, Kershen et al. 2004). We have referred to this strain as 
Csf1r-EGFP in the text. For studies using inducible expression of a constitutively active IKKβ 
mutant (cIKKβ) in macrophages, female Csf1r-rtTA mice were mated with male Tet-O-caIKKβ 
mice to produce IKFM offspring (Connelly, Barham et al. 2011). To induce cIKKβ expression, 
timed pregnant dams were given doxycycline-containing water (2g/L) ad libitum beginning at 
E14 until E18. For timed pregnant matings, embryonic day 0 (E0) was defined as the morning of 
vaginal plug discovery.   
 
Macrophage Isolation 
For isolation of fetal macrophages in gene expression and flow cytometry experiments, fetal 
lungs were dissected free of surrounding tissues and placed in cold PBS. Lung tissue was 
dissected, minced, and enzymatically digested with DNase (30ug/ml) and collagenase 
(0.7mg/ml) at 37° C for 30 min. The cell suspension was passed through a 70 µm cell strainer 
and collected by centrifugation. For gene expression, fetal cells were resuspended in the presence 
of anti-CD11b-conjugated microbeads and passed through a magnetic separation column 
(Miltenyi Biotec). CD68 staining confirmed that this isolation technique resulted in >95% 
macrophages. For IKFM samples, macrophages were isolated from each embryo and cultured 
separately in the presence of doxycycline.  
Adult lung macrophages were isolated by bronchoalveolar lavage. Lung lavage was 
repeated three times with cold PBS. Cells were cultured and treated the same as fetal 
macrophages. To isolate peritoneal macrophages, adult mice received an intraperitonal injection 
of 2 mL 3% thioglycollate medium. After 72h, the peritoneum was lavaged three times with cold 
PBS to collect macrophages. All macrophages were plated in RPMI 1640 with 10% FBS. After 
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1h in culture, macrophages were gently washed with PBS and treated with LPS (250 ng/ml), IL-
4 (5 ng/ml), or IL-13 (10 ng/ml) for 4h.   
 
RNA isolation and real-time PCR measurement 
RNA isolation, cDNA synthesis, and real-time PCR were performed on whole lung or isolated 
macrophages using standard techniques. Tissue and cells were stored and homogenized 
(TissueRuptor, Qiagen) in TRIzol (Invitrogen). After total RNA isolation, first strand cDNA was 
synthesized using an oligo(dT) primer and Superscript III (Invitrogen). Real time PCR was 
performed using either unlabeled oligonucleotides with SYBR Green or TaqMan probes. PCR 
was performed using either an iQ5 or CFX96 thermocycler (Bio-Rad). Gene expression 
comparisons were represented using 2-ΔΔCt method. Experiments were performed at least three 
independent times. Data between groups were analyzed by comparing ΔCT values using a 
multiple regression analysis model or the Mann-Whitney U test. 
 
Tissue processing and immunolabeling 
Mouse lung tissue was fixed, processed, and immunolabeled using standard techniques. 
Dissected lung tissue was fixed in 4% paraformaldehyde (Electron Microscopy Sciences), 
processed through a sucrose gradient, and frozen in OCT media (Tissue-Tek). Frozen tissue 
sections (10 µm thick) were postfixed in 2% paraformaldehyde, permeabilized in 0.1% TritonX-
100 (Thermo Scientific), and blocked with 5% normal donkey serum for 1h at room temperature. 
Tissue sections were incubated with antibody overnight at 4˚ C. Alexa-conjugated secondary 
antibodies (Invitrogen) were used for visualization. Following antibody labeling, nuclei were 
labeled with DAPI or DRAQ5. 
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Imaging and image analysis 
Confocal images were acquired using a Leica TCS SPE (Leica Microsystems) laser scanning 
confocal microscope. Widefield fluorescence images were obtained using an Olympus IX81 
microscope equipped with Hamamatsu Orca ER CCD monochrome camera and Slidebook 
software (Olympus). All microscopy images were saved in Tagged Image Format and imported 
into Photoshop (Adobe Systems) for processing. Images for comparison were identically 
processed. Immunofluorescence intensity measurements (relative fluorescent units) of individual 
macrophages were performed in Slidebook. A reference circle outlined a masked area over each 
macrophage. Relative fluorescent units for each channel were measured within the masked area 
and plotted against CD68 intensity values.   
 
Flow cytometry and FACS 
The following antibodies were used for flow cytometry and FACS experiments: CD11b-V450, 
CD86-PE-Cy7, Gr1 PerCP-Cy5.5, and CD45 APC-Cy7 (BD Bioscience); CD204-AF647, CD68-
FITC, and CD206-PE (AbD Serotec); F4/80-PE (Invitrogen); CD11c-Pe-Cy5 (BioLegend). 
Viable cells were identified using the LIVE/DEAD Fixable Red Dead Cell Stain Kit or the 
LIVE/DEAD Fixable Blue Dead Cell Stain kit (Invitrogen). Fetal and adult macrophages were 
digested as previously described. Cells were resuspended in ACK Lysing buffer (Invitrogen) to 
lyse red blood cells. Cells were blocked with 3% FBS for 15min and incubated with primary 
antibodies against surface markers for 30-60min on ice. For intracellular antibody staining, we 
used the Intracellular Fixation and Permeabilization kit (eBioscience). Flow cytometry 
measurements were conducted using a BD Fortessa, and flow sorting was conducted on a BD 
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FACSAria III.  For flow cytometry gating, the initial gate was based on FSC-A against SSC-A. 
Doublets were excluded with two gates: FSC-A against FSC-H, followed by SSC-A against 
SSC-H. Viability gating selected cells that were negative for the LIVE/DEAD fixable Red or 
Blue Dead Cell stain. Out of viable cells, CD45+ cells identified the population of hematopoietic 
cells. For FACS gating, the initial gate was FSC-A against SSC-A, followed by doublet 
exclusion with FSC-A against FSH-A and SSC-A against SSH-A.  CD45+ cells were separated 
into CD11bhiF4/80lo and CD11bloF4/80hi.  These cell populations were sorted directly into Trizol. 
 
Results 
 
Fetal lung macrophages differentially express phenotype markers during development. 
 Lung macrophages are clearly important in neonatal lung immunity and disease. 
However, the differentiation and maturation of lung macrophages during fetal development is 
just now being characterized. We measured the expression of various macrophage population 
markers in developing mouse lungs. As shown in Figure 3.1, cells expressing the pan-
macrophage marker CD68 were present in the fetal lungs throughout development. The pro-
inflammatory macrophage marker CD86, however, was rarely detected at E13 and E15. Cells 
expressing CD86 were more prevalent later in gestation and in the adult lung. Ym1 and CD206 
are markers of alternatively activated macrophages, found commonly associated with tumors or 
in chronic inflammation models. While we did not detect Ym1 expression in E13 and E15 mouse 
lungs, staining appeared at E18 and was abundant in adult lungs. In contrast, CD206 was widely 
present at E13, and appeared to label similar numbers of cells as CD68 throughout mouse lung 
development. Macrophage galactose N-acetyl-galactosamine–specific lectin 1 (Mgl1/2) was 
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expressed both by macrophages and airway dendritic cells in the adult lung.  Interestingly, 
Mgl1/2 expression in the fetal lung appeared at E15 and was restricted to cells with a more round 
macrophage morphology. Macrophage markers were therefore differentially expressed 
throughout fetal lung development and with distinct temporal patterns.  
 
 Gene expression experiments showed similar patterns of macrophage marker expression 
throughout lung development (Fig. 3.1F-H). CD68 expression increased in postnatal and adult 
lung, suggesting either a higher CD68 expression or an increase in number of CD68+ 
macrophages. The pro-inflammatory markers CD86 and Ido1 also increased during development, 
being most highly expressed in adult lung. Similar to the immunofluorescence data in Fig. 3.1D, 
CD206 gene expression was relatively constant throughout lung development (Fig. 3.1G). In 
contrast, expression of other alternatively activated macrophage markers was higher in more 
mature lungs. While Ym1 expression first increased at P7, fibrinogen-like protein 2 (FGL2), 
another marker of alternatively activated macrophages, increased earlier during development, 
plateauing around E17. Markers of alternatively activated macrophages and airway dendritic 
cells (Mgl1/2, CD11c, CD103) were more highly expressed in postnatal and adult lungs (Fig. 
3.1H). Both immunofluorescence and gene expression data therefore support developmental 
regulation of macrophage differentiation and maturation. The temporal changes in expression 
were distinct for each marker tested and did not clearly follow pro-inflammatory or alternative 
activation paradigms.  
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 Figure 3.1. Macrophage marker expression during mouse lung development. (A-E) Frozen 
sections of E13, E15, E18 or adult mouse lungs were immunostained with Abs against the pan-
macrophage marker CD68 (A) the pro-inflammatory macrophage marker CD86 (B) the 
alternative activation markers Ym1 (C), CD206 (D) and Mgl1/2 (E). Smooth muscle and 
myofibroblasts immunolabeled with anti-α-SMA in (A-C; red); epithelial cells immunolabeled 
with anti-E-cadherin in (D,E; red). Nuclei were labeled with DRAQ5. Images obtained by laser 
scanning confocal microscopy. (F-H) Gene expression of macrophage markers in E12, E13, E15, 
E17, P1 and adult mouse lungs. (F) Expression of the pan-macrophage marker CD68 and 
proinflammatory markers CD86 and INDO increased during later stages of development and 
following delivery. (G) Expression of the alternative activation markers CD206, Ym1, and FGL2 
each had distinct temporal expression patterns. (H) The alveolar macrophage/dendritic cell 
markers Mgl1/2, CD11c, and CD103 were expressed highest in postnatal and adult lung. (n = 4 
litters for each embryonic time point, 4 lungs from individuals at P1 and adult; * p < 0.05).	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 Because multiple macrophage markers were expressed in the developing lung, we next 
tested if these various markers represented distinctly separate macrophage populations. We 
immunostained multiple sections of developing mouse lungs obtained at E15 with both CD68 
and various population-specific markers. Individual cell fluorescence intensity was then 
measured for all cells expressing either macrophage marker. As shown in Figure 3.2, CD86 
expression in CD68+ macrophages was variable in E15 lungs. The separation of CD68 and CD86 
expression was more apparent in adult lung, with CD86-expressing cells having lower CD68 
staining intensity. Consistent with data in Figure 3.1, only a minority of CD68+ macrophages in 
E15 lungs expressed Mgl1/2, while a larger population of adult macrophages and airway 
dendritic cells expressed both CD68 and Mgl1/2 (Fig. 3.2C-D). CD206 was expressed 
throughout lung development. However, the intensity of CD206 staining in E15 lungs varied 
(Fig. 3.2E). In contrast, CD206 expression in adult CD68+ cells was relatively low. Using this 
approach to identify macrophage populations in situ revealed differences in relative marker 
expression between E15 and adult lung macrophages. However, this immunostaining approach 
was not able to clearly identify distinct populations of macrophages in the fetal lung with relative 
differences in expression levels or patterns.           
 
 We next tested for the presence of subpopulations of fetal mouse lung macrophages by 
flow cytometry (Figure 3.3). Lung macrophages were isolated from single cell suspensions 
obtained from fetal (E15 and E18), postnatal day 7 (P7), and adult Csf1r-EGFP lungs. In these 
mice, GFP-positive cells uniformly expressed CD68 (Fig. 3.3A). Viable, CD45+, Csf1r-EGFP+ 
cells (Fig. 3.3B) were analyzed based on expression of Gr1, CD86, CD11c, CD11b, and F4/80.  
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Figure 3.2. Comparison of macrophage populations in fetal and adult mouse lungs. (A-F) Frozen 
sections of E15 and adult mouse lungs were immunostained with Abs against CD68 and CD86 
(A-B), Mgl1/2 (C-D), or CD206 (E-F). Nuclei were labeled with DAPI. Macrophages labeled in 
were identified by widefield fluorescence microscopy. Multi-channel fluorescence of each cell 
was measured and plotted to demonstrate potential populations of cells with differing expression 
levels. Macrophages in E15 mouse lungs expressed relatively similar marker levels, with the 
exception of CD206 (E), which had a larger expression range. Adult lungs contained more 
clearly identified populations of macrophages based on CD86 (B) and Mgl1/2 (D) expression. (n 
= 4 different lung samples from each stage, 20 images were measured per lung). 
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 Figure 3.3. Developmental maturation of lung macrophages occurs after birth.  Csf1r-EGFP+ 
cells were positive for CD68 (A). CD45+ cells were gated for GFP expression (B). (C-F) Flow 
cytometric analysis of Csf1r-EGFP+, CD45+ macrophages from E15, E18, P7, and adult mouse 
lungs. CD11b and Gr1 expression show potential neutrophil populations in E18, P7, and adult 
lungs (C). Broad expression of CD11c+ (D), and CD11b+/F4/80+ (E) cells were detected in P7 
and adult lungs, consistent with mature alveolar macrophage differentiation.  CD11bhiF4/80lo and 
CD11bloF4/80hi populations were gated and analyzed for CD86 expression (F). (n = 3 adult mice, 
3 E15 litters, 3 E18 litters, 3 P7 pups). 
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Cells from E15 lungs expressed Gr1, CD11b, and F4/80, but the patterns of expression suggest 
less diversity when compared to macrophages from more mature lungs. Expression of CD11c 
was low in E15 lungs, increased at E18, and was clearly present by P7 (Fig. 3.3D). Distinct 
populations of CD11c+ cells were observed in P7 and adult lungs, consistent with previous data 
showing CD11c expression in mature alveolar macrophages (Zaynagetdinov, Sherrill et al. 2013; 
Guilliams, Dr Kleer et al. 2013). This flow cytometry expression pattern followed the real time 
PCR data, where CD11c expression was low in fetal lung but increased at birth (Fig. 3.1H).   
 
The most consistent separation of E15 macrophages into distinct subpopulations was 
observed with gating CD11b+F4/80+ cells (Fig. 3.3E). The distribution of CD11bhiF4/80lo and 
CD11bloF4/80hi cells in E15 lungs was consistent with recently reported data suggesting these 
two subpopulations may arise from distinct cellular precursors (Schulz, Gomez et al. 2012). 
Interestingly, macrophage subpopulations based on CD11b and F4/80 expression appeared to be 
more diverse in P7 and adult lungs. These data confirmed that the fetal lung does contain 
subpopulations of macrophages, but with less diversity than more mature lungs. To test if the 
CD11bhiF4/80lo and CD11bloF4/80hi subpopulations had uniquely different proinflammatory 
markers, we compared CD86 expression in both populations. As seen in Figure 3.3F, both 
CD11bhiF4/80lo and CD11bloF4/80hi macrophages expressed CD86 in E15 lungs.  
 
 We next tested if fetal lung macrophages responded to the proinflammatory stimulus LPS 
and the alternative activation cytokines IL-4 and IL-13 (Figure 3.4). LPS treatment of E15 fetal 
lung macrophages increased expression of CXCL-10, CCL-3, IL-1β, and TNFα, consistent with 
a robust proinflammatory response. IL-4 and IL-13 each inhibited expression of CXCL-10 and  
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Figure 3.4. Transcriptional response of fetal mouse lung macrophages in response to LPS, IL-4, 
and IL-13. (A) Macrophages were isolated from E15 fetal C57/BL6 mouse lungs and treated 
with LPS (250 ng/ml), IL-4 (5 ng/ml), and IL-13 (10 ng/ml) for 4 h as indicated. Following RNA 
isolation, real time PCR measured expression of proinflammatory markers (CXCL10, CCL-3, 
IL-1β, TNFα) and alternative activation markers (CCL-17, CD206). For each marker, expression 
was compared to control, untreated samples (* p < 0.05; n = 6 litters). (B) Adult mouse alveolar 
macrophages were isolated by bronchoalveolar lavage and cultured with LPS, IL-4, and IL-13 as 
in (A) (* p < 0.05; n = 3). (C) To demonstrate control macrophage response to both LPS and IL-
4 and IL-13, peritoneal macrophages were isolated from thioglycollate-injected C57/BL6 adult 
mice. Isolated cells were cultured in the presence of LPS, IL-4, or IL-13 for 4 h and gene 
expression measured by real time PCR (* p < 0.05; n = 3 mice for adult and peritoneal samples, 
6 litters used for E15 samples). (D) IL-4R components were measured in macrophages from 
different stage lungs by real-time PCR. (* p < 0.05; n = 3).   
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CCL-3, but did not dampen the response to LPS. Treating E15 macrophages with IL-4 or IL-13 
caused only a modest and statistically insignificant increase in the alternative activation markers 
CCL-17 and CD206. However, adding both LPS and IL-4/IL-13 did increase CCL-17 expression 
above levels seen with any agonist alone. In adult lung macrophages, IL-4 and IL-13 both 
increased CCL-17 and CD206 expression (Fig. 3.4B). Interestingly, IL-4 and IL-13 also 
upregulated expression of CCL-3 and IL-1β, although much less than LPS (Fig. 3.4B). As an 
additional comparison, IL-4 and IL-13 decreased CXCL-10 and increased CCL-17 and CD206 in 
adult peritoneal macrophages (Fig. 3.4C). Therefore E15 fetal lung macrophages responded 
similarly to LPS as adult macrophages, but appeared to have reduced sensitivity to the alternative 
activation cytokines IL-4 and IL-13. This reduced sensitivity to IL-4 and IL-13 could be due to 
low receptor expression in E15 cells compared to adult cells, as suggested by gene expression 
data for IL4Rα, IL13R1, etc. (Fig. 3.4D). LPS did not significantly change receptor gene 
expression in E15, E18, or adult lung macrophages (Fig. 3.4D).   
 
 We used a transgenic approach to further test if inflammatory signals and specifically 
NF-κB activation could regulate fetal lung macrophage development and maturation. IKFM 
double transgenic mice express a constitutively active IKKβ mutant in macrophages upon 
doxycycline exposure (Blackwell et al. 2011; Connelly et al. 2011). Pregnant dams were given 
doxycycline from E14-E18; lung macrophages were isolated from E18 IKFM and littermate 
controls. We then measured expression of the pro-inflammatory mediators CXCL-10, CCL-3, 
IL-1β, and TNFα in addition to the alternative activation markers CCL-17 and CD206 (Figure 
3.5). IKFM macrophages expressed higher levels of CXCL-10, CCL-3, IL-1β, and TNFα, 
consistent with NF-κB activation (Fig. 3.5A-B). While E18 control macrophages  
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 Figure 3.5. NF-κB activation in fetal mouse lung macrophages stimulated a proinflammatory 
response and reduced the response to IL-4 and IL-13. IKFM mice expressing a tetracycline-
inducible constitutively active IKKb mutant were given doxycycline from E14-E18. Fetal lung 
macrophages from E18 IKFM fetal mouse lungs and littermate controls were cultured with IL-4 
or IL-13. (A-C) RNA was isolated and expression of proinflammatory markers (CXCL10, CCL-
3, IL-1β, TNFα) and alternative activation markers (CCL-17, CD206) were measured by real 
time PCR (* p < 0.05; n = 5 litters).  
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expressed increased CCL-17 and CD206 following IL-4 and IL-13 treatment, IL-4 and IL-13 had 
less effect on IKFM macrophages (Fig. 3.5C). These data suggested that fetal lung macrophage 
NF-κB activation could promote functional resistance to IL-4 and IL-13.  
 
Immunostaining of IKFM and control lung sections did not reveal dramatic differences in 
the relative populations of cells expressing CD86, Mgl1/2, or CD206 in situ (Figure 3.6). 
However, flow cytometry showed shifts in relative CD11b and F4/80 expression. The increased 
relative percentage of CD11bloF4/80hi macrophages in IKFM lungs was consistent between litters 
(Fig. 3.7A-C). These CD11bloF4/80hi cells also expressed higher levels of IL-1β (Fig. 3.7D). 
Differences in gene expression were not due to selective transgene expression, as the cIKKβ 
transgene was expressed in both CD11bhiF4/80lo and CD11bloF4/80hi cell populations (Fig. 3.7E). 
We previously measured increased macrophage cell number in IKFM lungs (Blackwell, Hipps et 
al. 2011). This increase could be due to proliferation of resident lung macrophages. 
Immunostaining showed that IKFM lungs contained a higher percentage of macrophages 
expressing phospho-HistoneH3 (Fig. 3.7F) and Ki67 (Fig. 3.7G). The increase in proliferation 
was associated with the relative increase in cyclinD1 expression in CD11bloF4/80hi macrophages 
(Fig. 3.7H). Therefore, in addition to stimulating expression of inflammatory mediators, NF-κB 
activation increased macrophage proliferation within fetal lung tissue. 
 
The increase in CD11bloF4/80hi macrophages in IKFM lungs is consistent with increased 
differentiation, as mature alveolar macrophages are also CD11bloF4/80hi (Zaynagetdinov, Sherrill 
et al. 2013). Similarly, we measured increased CD204 and CD206 expression in IKFM lungs, 
both of which are expressed on the surface of mature alveolar macrophages (Fig. 3.7I). IKFM 
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Figure 3.6. NF-κB activation in fetal mouse lung macrophages did not cause major shifts in 
macrophage populations. IKFM female mice were given doxycycline from E14-E18. Lungs from 
IKFM and control littermates were isolated at E18. (A-C) Frozen sections of littermate control 
and IKFM fetal lungs were co-immunostained with Abs against the pan-macrophage marker 
CD68 (green) and proinflammatory marker CD86 (A) or the alternative activation markers 
Mgl1/2 (B) and CD206 (C). Nuclei were labeled with DAPI. (D-F) Macrophages labeled in (A-
C) were identified by widefield fluorescence microscopy. Multi-channel fluorescence of each 
cell was measured and plotted to demonstrate potential populations of cells with differing 
expression levels. Sum fluorescent intensity of individual macrophages was measured using 
Slidebook software. The patterns of macrophage marker intensity were similar between IKFM 
and control littermates. (n = 3 control littermate and 3 IKFM lungs, 20 images were counted 
from each lung). 
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Figure 3.7. NF-κB activation increased alveolar macrophage phenotype markers in fetal mouse 
lung.  Single cell suspensions were isolated from E18 IKFM and control-littermate fetal lungs.  
(A,B) Viable, CD45+CD68+ cells were gated on F4/80 and CD11b expression. IKFM lungs 
contained a more identifiable subpopulation of CD11bloF4/80hi macrophages (B). (C) Percentage 
of CD11bloF4/80hi macrophages within the CD68+ population was increased in IKFM lungs 
compared to control littermates. Four independent litters are shown (* p = 0.04). (D) 
CD11bloF4/80hi macrophages produced higher mRNA levels in both IKFM and littermate-
controls. (E) Both CD11bhiF4/80lo and CD11bloF4/80hi macrophages from IKFM fetal lungs 
expressed the cIKKβ transgene when exposed in utero to doxycycline. (F-G) Frozen sections of 
E18 control littermate and IKFM lungs were immunostained stained with the macrophage 
marker CD68 and phosphohistone H3 (PHH3) or Ki67. IKFM lungs had increased number of 
PHH3+ and Ki67+ macrophages that were not due to overall increased cell proliferation 
throughout the lung. (H) CD11bloF4/80hi macrophages expressed increased cyclinD1 mRNA in 
both IKFM and control littermate fetal lungs (* p < 0.05; n = 3 control and 3 IKFM). (I) IKFM 
macrophages expressed increased CD204 and CD206. (J-K) Increased Gr1 expression in IKFM 
macrophages was only detected in the CD11bhiF4/80lo subpopulation (J), while CD11bloF4/80hi 
macrophages from IKFM lungs expressed slightly elevated levels of CD11c (K). (n = 4 litters for 
A-C, I-J; 3 control and IKFM samples for D, E, H; 4 individual control and IKFM lungs were 
used in F-G, with approximately 10 images per lung).  
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lungs also contained higher numbers of Gr1+ macrophages (Fig. 3.7J), suggesting possible 
recruitment of fetal monocytes. Importantly, Gr1 expression was only detected in CD11bhiF4/80lo 
populations. Increased macrophage differentiation in IKFM lungs did not lead to large increases 
in CD11c, which remained very low in both CD11bhiF4/80lo and CD11bloF4/80hi cells (Fig. 
3.7K). Therefore, NF-κB stimulated changes in macrophage marker expression were most 
consistent with lung macrophage maturation and did not follow a clear 
proinflammatory/alternative activation or M1/M2 paradigm. 
 
Discussion 
 
Fetal lung macrophages undergo significant differentiation and maturational changes 
during development. While fetal lung macrophages expressed relatively consistent levels of 
CD68 and CD206 at each stage tested, other macrophage lineage markers increased significantly. 
Both proinflammatory and alternative activation markers increased during development without 
following a consistent M1/M2, proinflammatory/alternative activation paradigm. Developing 
lung macrophages were functional, as immature macrophages from E15 mouse lungs responded 
to the proinflammatory stimulus LPS. The partial response to IL-4 and IL-13 suggest that E15 
lung macrophages may indicate a relative functional polarization toward a proinflammatory 
phenotype.  
 
The notion of M1/M2 macrophage polarization derives largely from studies using tumor-
associated macrophages and chronic inflammation models (Mitsuhashi et al. 2013; Starossom et 
al. 2012; Mantovani and Locati 2009). So while activation of M1 macrophages and M2 
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polarization may contribute to disease, this classification paradigm may not directly apply to the 
developmental phenotypes of lung macrophages. Adult alveolar macrophages express both M1 
and M2 markers (Zaynagetdinov et al. 2013). We speculate that the constant exposure to inhaled 
pathogens and particulates requires that lung macrophages possess both robust killing activity 
(typically thought of as M1) and the ability to resolve or suppress inflammation and injury (an 
M2 process).  Recent work demonstrated that macrophages in the postnatal lung express the 
alternative activation or M2 genes, Arg1, CCL-17, and Mrc1 (Jones, Williams et al. 2013).  
These studies also showed a downward trend of expression for some proinflammatory genes in 
later postnatal stages (Jones et al. 2013). However, mature alveolar macrophages also possess the 
ability to mount a strong proinflammatory immune response. Recent publications have in fact 
expanded M1/M2 classification into a spectrum model for classifying macrophage phenotype 
(Xue et al. 2014). Additionally, tissue macrophages in various developing organs appear to 
acquire unique phenotypic features (Laskin et al. 2001; Guillemin and Brew 2004). How these 
unique expression patterns might regulate differential or tissue-specific macrophage function 
remains unclear. 
  
During lung development, the relative abundance of CD11bhiF4/80lo and CD11bloF4/80hi 
macrophages undergo dynamic shifts. Distinct subpopulations are seen early in lung 
development and again around the time of birth as fetal monocytes/macrophages develop into 
postnatal and adult lung macrophages. Consistent with Guilliams et al. (Guilliams et al. 2013), 
we also observed increasing CD11c expression when fetal macrophage subpopulations 
differentiated into alveolar macrophages. Maturational changes in macrophage marker 
expression correlated with postnatal migration of macrophages into the alveolar air space. Our 
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data showing differences in CD11b and F4/80 expression with maturation and activation suggest 
that NF-κB signaling accelerates macrophage differentiation. IKKβ activity in fetal macrophages 
increased the percentage of CD11bloF4/80hi cells within the developing lung. The CD11bloF4/80hi 
subpopulation expressed higher levels of IL-1β mRNA, suggesting macrophage activation leads 
to the developmental maturation or recruitment of a proinflammatory subpopulation. However, 
the overall increase in the M2-like scavenger receptors CD204 and CD206 again emphasizes that 
lung macrophage differentiation is more complex than a simple M1/M2 classification. Previous 
studies show NF-κB activation also influences dendritic cell maturation. Deleting both RelA and 
p50 subunits of NF-κB prevented normal CD11c+ dendritic cell development in the livers of 
mice in adoptive transfer studies (Ouaaz, Zheng et al. 2002). In studies using GM-CSF and IL-4 
to induce dendritic cell differentiation and maturation in human monocytes, NF-κB inhibition 
reduced expression of CD1a and DC-SIGN and reduced dendritic progenitor cell number (van de 
Laar, van de Bosch et al. 2010). How NF-κB signaling might interact with other factors 
regulating macrophage development (i.e. PU.1, CEBP, Myb, Maf) also remains unclear (Sharif 
et al. 2007).  
 
Recent findings demonstrating proliferation and self-renewal of resident tissue 
macrophages have challenged the notion that macrophage populations are solely comprised of 
recruited monocytic cells (Yona et al. 2013). Local production of the macrophage mitogens CSF-
1 and CCL-2 stimulate macrophage proliferation within tissues via JAK/STAT signaling 
pathways (Pierce et al. 1990; Pixley and Stanley 2004; Lin et al. 2002; Qian et al. 2011). Here 
we showed that transgenic expression of a constitutively active IKKβ transgene in macrophages 
also stimulated proliferation within fetal mouse lungs. NF-κB activation could increase 
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production of intermediate factors that drive cell proliferation via autocrine loops or via 
neighboring cells residing within a multicellular niche. Alternatively, increased IKKβ activity 
could facilitate signaling through additional intracellular pathways connected with cell 
proliferation. In cancer cell models, NF-κB promotes cyclinD1 expression and is required for 
cell growth and proliferation (Montano-Almendras et al. 2012; Tang et al. 2013). While both 
CD11bhiF4/80lo and CD11bloF4/80hi macrophage populations in IFKM fetal mouse lungs 
expressed the cIKKβ transgene, macrophages with the highest F4/80 and IL-1β expression also 
contained the highest expression of cyclinD1. These data suggested that more mature 
CD11bloF4/80hi cells in the fetal lung may have increased capacity for both cytokine expression 
and proliferation.  
 
Our data demonstrate that immature fetal lung macrophages respond robustly to LPS 
exposure. The relative pro-inflammatory and anti-inflammatory functions of developing lung 
macrophages remain unclear. How IL-4 and IL-13 regulate these functions may be important in 
disease, as IL-13 induces Th2 inflammation in asthmatic lungs (Zhu et al. 2002; Cho et al. 2006). 
Previous studies comparing adult and neonatal monocytes from different sources measured 
variable cytokine responses following exposure to TLR agonists (Kollmann et al. 2009; Berner et 
al. 2002; Taniguchi et al. 1993). Consistent differences were reported primarily in interferon 
production in response to co-cultures and macrophage activators (Wilson et al. 1986; Taylor and 
Bryson 1985; Scott et al. 1997).  However, relative differences in production of cytokines such 
as IL-1β or TNFα and changes to the kinetics of transcriptional activation and subsequent 
silencing could still lead to important physiological differences in the innate immune response 
within immature lungs.  
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The ability of macrophage activation to increase maturation as well as release 
inflammatory mediators could have significant implications in disease. Preterm infants are often 
exposed to multiple agents capable of activating immature but functional lung macrophages 
(Newton 1993; Martius and Eschenbach 1990; Speer 2009). Early macrophage activation in 
IKFM mice disrupts structural lung morphogenesis, possibly modeling BPD pathogenesis in 
human patients. In addition, inflammation-induced macrophage maturation might sensitize the 
lung innate immune response to repeated infectious challenges. This two-hit hypothesis has been 
frequently suggested as important in the pathogenesis of neonatal chronic lung disease and BPD 
(Jobe 1999; Wright and Kirpalani 2011). Increased macrophage maturation in the immature lung 
and reduced responsiveness to IL-4 and IL-13 could limit the ability to resolve lung 
inflammation and promote wound healing. Investigating these new paradigms in macrophage 
biology and development will lead to new therapeutic strategies for pediatric lung disease. 
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CHAPTER IV 
 
IL-1beta and Inflammasome Activity Link Macrophage Activation with Abnormal Lung 
Airway Morphogenesis 
 
Introduction 
 
Lung infection and inflammation cause significant illness and death in newborn infants. 
Both adult and neonatal lungs contact the atmosphere and inhale various pathogens and injurious 
agents. However, the particular susceptibility of neonatal lungs to disease suggests 
developmental immaturity of the lung innate immune system. In preterm infants, infection and 
inflammation injures the developing lung, preventing normal airway morphogenesis and causing 
bronchopulmonary dysplasia (BPD) (Romero et al 2002; Jobe 2003). Developing specific 
therapies to prevent BPD have been restricted by our lack of complete understanding of how the 
lung innate immune system matures and how activation of immunity disrupts normal 
developmental pathways.  
Inhaled microbes and particles interact with multiple cell populations in the lung. Among 
the various lung cells, macrophages are the primary sites of inflammatory activation (Blackwell 
et al. 2011). Even in the fetal lung where immature macrophages reside largely in the 
interstitium, macrophages are the major cells that respond to microbial products and release 
inflammatory mediators. Other cell populations including airway epithelia, vascular endothelia, 
and mesenchymal cells play supporting roles in the innate immune response and are targets of 
macrophage-derived soluble inflammatory mediators. Even though macrophages appear to be 
required for initiating lung inflammation, the effects of microbial products on lung development 
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and airway morphogenesis require innate immune signaling and NF-κB activation in target 
mesenchymal and epithelial cells (Benjamin et al. 2010). Therefore connecting macrophage 
activation and abnormal lung development requires production and release of paracrine 
inflammatory mediators. 
Among the soluble inflammatory mediators released by lung macrophages, IL-1β appears 
to play a key role in neonatal lung injury. Recent studies have linked IL-1β signaling to 
hyperoxia-induced defects in alveolar development in neonatal mice (Nold et al. 2013). 
Transgenic IL-1β overexpression can inhibit normal fetal lung development (Bry et al. 2007). 
Interestingly, these effects appear developmentally regulated, with more pronounced effects 
during the late canalicular and saccular stages of fetal lung development. Similarly, we 
previously observed that macrophage activation early in lung development did not have the same 
inhibitory effects on morphogenesis as during the later stages (Blackwell et al. 2011). These data 
suggested that the effects of IL-1β on lung morphogenesis were developmentally regulated, 
either at the level of IL-1β release or the responsiveness to IL-1β by target cells. 
Here we use complementary mouse models to demonstrate that IL-1β is the key cytokine 
connecting activation of the initial inflammatory response in fetal lung macrophages and 
abnormal saccular airway branching morphogenesis. Consistent with this mechanism, functional 
inflammasome activity was required and sufficient for abnormal late stage fetal lung 
development. While target mesenchymal cells in the developing lung were responsive to 
inflammatory mediators at each stage tested, the expression of multiple inflammasome 
components were expressed at much higher levels in newborn and adult lung macrophages. In 
addition, inflammatory activation accelerated the normal developmental expression of the 
inflammasome. Development of a functional inflammasome and release of IL-1β following 
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inflammatory activation are therefore required for the defects in lung development similar to that 
seen in human disease. 
 
Methods and Materials 
 
Reagents 
The following antibodies were used in explant cultures and were obtained from R&D Systems: 
anti-IL1β, anti-TNFα, goat IgG, and rat IgG. Gel-purified Escherichia coli LPS (O55:B5) was 
purchased from Sigma-Aldrich, and Caspase-1 Inhibitor I (YVAD-CHO) was purchased from 
Calbiochem. The following antibodies were used for immunofluorescence: rat anti-CD68 
(Acris), rabbit anti-caspase 1 p10 (Santa Cruz Biotechnology), rabbit anti-NALP1 (NLRP1, 
Santa Cruz Biotechnology), rabbit anti-ASC (Abcam), and rabbit anti-Cryopyrin (NLRP3, Santa 
Cruz Biotechnology). ProLong Gold with DAPI mounting media and Alexa-conjugated 
secondary antibodies (AF488, AF555) were obtained from Invitrogen. The nuclear stain DRAQ5 
was purchased from Thermo Scientific. Fetal lung mesenchymal cells were treated with 
recombinant IL-1β (rIL1β, R&D Systems), recombinant TNFα (rTNFα, R&D Systems), 
recombinant IL18 (rIL18, MBL International Corporation), and Pam3Cys-Ser-(Lys)4 (Millipore). 
Luciferase activity was measured with the luciferase assay system from Promega. Cells were 
cultured in media from Corning’s Cellgro and 10% FBS (Thermo Scientific). DNase I from 
bovine pancreas type IV (DNase) and collagenase from clostridium histolyticum type XI were 
purchased from Sigma-Aldrich. 
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Mouse strains and lung explant culture 
Animal experiments were approved by the Institutional Animal Care and Use Committee from 
the University of California at San Diego. C57Bl/6 mice were used as wild-type controls and 
were obtained from Harlan Laboratories. IL-1β-/-, NLRP3L351PCreL, and IKFM mouse strains 
were developed and described previously. To generate NLRP3L351PCreL mutants, homozygous 
LysM-Cre mice were crossed with heterozygous NLRP3L351P mice. NLRP3L351PCreL offspring 
have macrophages with constitutively active NLRP3 inflammasome. IKFM mice are a 
doxycycline inducible model obtained from Csf1r-rtTA mice crossed to a Tet-O-cIKKβ. IKFM 
mice have macrophages with constitutively active IKKβ. Doxycycline-containing water (2g/L) 
was given to pregnant dams to induce transgene expression in IKFM embryos. The morning of 
plug identification was embryonic day 0 (E0). Fetal lung explant isolation and culture has 
previously been described. Briefly, E15 fetal lungs were isolated, minced into approximately 
1mm size, and cultured on a transwell with an air-liquid interface. Brightfield images of explants 
were taken at 24h and 72h. Saccular airway branching was quantified as the number of branches 
newly formed between 24h and 72h. For luciferase activity in NGL explants, explants were 
isolated and ground in reporter lysis buffer (Promega) and measured with a luciferase assay 
system (Promega). 
 
Fetal lung macrophage isolation 
Isolation of fetal lung macrophages has previously been described. Briefly, fetal lungs are 
dissected and enzymatically digested with DNase (30 ug/ml) and collagenase (0.7 mg/ml). Cells 
were passed through a 70 um cell strainer to obtain a single cell suspension. Adult alveolar 
macrophages were isolated by bronchoalveolar lavage as previously described. 
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Tissue processing, immunolabeling, and imaging 
Fetal mouse lung tissue was dissected and fixed in 4% paraformaldehyde (Electron Microscopy 
Sciences), washed, and processed through a sucrose gradient for embedding into OCT media 
(Tissue-Tek) or a dehydrating series for embedding into paraffin. For immunofluorescence on 
frozen sections, Alexa-conjugated secondary antibodies aided antibody visualization and 
DRAQ5 labeled nuclei. Confocal images were acquired using a Leica TCS SPE (Leica 
microsystems) laser-scanning confocal microscope. Eosin (Ricca Chemical) and Mayer’s 
hematoxylin (Dako) were used on paraffin sections for H&E staining. Serial lung H&E sections 
were measured for fractional lung volumes of tissue and airspace. Intersection points of a grid 
overlay on H&E images were defined as tissue or airspace within ImageJ (NIH). Images from 
explants were obtained from an Olympus IX8I microscope with a Hamamatsu Orca ER CCD 
camera and Slidebook software or from a Touptek Toupcam with Toupview software. NGL 
explant GFP images were taken on a EVOS Cell Imaging System (Invirtrogen). 
 
Flow Cytometry 
The following antibodies were used for flow cytometry: CD11b-V450, CD86-Pe-Cy7, Gr1 
PerCP-Cy5.5, and CD45 allophycocyanin-Cy7 (BD Biosciences); CD204-AF647, CD68-FITC, 
and CD206-PE (AbD Serotec); F4/80-PE (Invitrogen); and CD11c-Pe-Cy5 (BioLegend). Viable 
cells were selected using the LIVE/DEAD Fixable Blue Dead Cell Stain Kit (Invitrogen). Fetal 
and adult lungs were digested to a single cell suspension with DNase and collagense. Red blood 
cells were lysed with ACK lysing buffer (Invitrogen). On ice, 3% FBS was used to block cells 
for 15 min, and was followed by incubation with cell surface antibodies for 30-60 min. 
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Intracelluar antibodies were incubated with cells for 30min on ice after using the Intracellular 
Fixation and Permeabilization Kit (eBioscience). Flow cytometry measurements were conducted 
on a BD LSR II. The gating strategy: Doublets were excluded based on FSC-A against FSC-H 
followed by SSC-A against SSC-H. Cells negative for LIVE/DEAD Fixable Blue Stain defined 
viable cells. Further gating was for CD45+ and CD68+ cells, which were separated into 
CD11bhiF4/80lo and CD11bloF4/80hi cells. 
Results 
 
IL-1β  inhibits fetal airway morphogenesis 
Macrophage activation inhibits normal lung morphogenesis. Soluble inflammatory 
mediators released by macrophages disrupt expression of key developmental genes in lung 
epithelia and adjacent mesenchyme. Since IL-1β and TNFα activated NF-κB in target 
mesenchymal cells, we tested if these mediators were required to link macrophage activation and 
abnormal airway morphogenesis. We initially used neutralizing antibodies against IL-1β and 
TNFα in a saccular stage fetal mouse lung explant model (Figure 4.1). As we previously 
demonstrated, adding E. coli LPS prevented the normal formation of new airways along the 
periphery of cultured explants. Including anti-IL1β in the culture media prevented this decrease, 
allowing normal airway branching (Figure 4.1B). However, anti-TNFα antibodies had no effect 
(Figure 4.1C). Including both anti-IL1β and anti-TNFα antibodies gave similar protection as 
anti-IL1β alone (Figure 4.1D). These initial experiments suggested that IL-1β signaling was 
required for LPS to prevent normal airway morphogenesis. The protective effects of anti-IL-1β 
did not appear to be due to overall inhibition of inflammation, as LPS induced similar CCL2  
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Figure 4.1. Inhibiting IL-1β activity protects fetal mouse lung explants from the effects of LPS. 
E15 fetal lung explants from C57Bl/6 mice were cultured under control conditions and in the 
presence of LPS (250 ng/ml), a neutralizing antibody to IL-1β (10ng/ml), or a neutralizing 
antibody to TNFα (10ng/ml). Explant images show LPS inhibits new airway branching, but anti-
IL-1β prevents this effect. Anti-ΤΝFα does not rescue lung branching in explants cultured with 
LPS. Explants treated with a combination of LPS, anti-IL1β, and anti-TNFα have normal airway 
branching. Brightfield images were obtained using a 4X objective. LPS inhibited the number of 
new branches explants formed between 24h and 72h. Control IgG was negligible on the effect of 
LPS. LPS had no effect on branching in explants cultured with anti-IL1β and anti-IL1β/anti-
TNFα. LPS increases gene expression of inflammatory cytokine, CCL-2, even in the presence of 
anti-IL1β and anti-TNFα. IL-1β-/- E15 fetal lung explants were cultured under control conditions 
and with LPS. LPS did not inhibit airway branching in IL-1β-/- explants, and the number of new 
branches was consistent between control and LPS treated explants. E15 fetal lung explants from 
C57Bl/6 mice were cultured in the presence of the caspase-1 inhibitor I (YVAD, 1 μM). YVAD 
protected fetal lung explants from the effects of LPS. n = at least 16 explants from 3 different 
litters, *p < 0.05, #p < 0.01.
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expression in anti-IL1β-treated explants (Figure 4.1F). To further test the requirement of IL-1β, 
we measured the effects of LPS on airway morphogenesis using fetal lung explants from IL-1β-/- 
mice (Figure 4.1G). LPS did not affect airway branching in these mutant lungs, further 
demonstrating that IL-1β release and signaling linked LPS-stimulated inflammation and 
abnormal airway formation. 
 
 Inflammatory activation in macrophages produces IL-1β precursor peptide that is cleaved 
by inflammasome-associated caspase-1 and secreted to the extracellular space (Dinarello 1998). 
Inhibiting inflammasome-associated caspase-1 activity prevents IL-1β release. To test the 
requirement of inflammasome-mediated cytokine release, we treated fetal lung explants with the 
peptide-based caspase-1 inhibitor Ac-Tyr-Val-Ala-Asp-CHO (Figure 4.1H). As seen in Figure 1, 
adding Ac-Tyr-Val-Ala-Asp-CHO to the explant media both prevented IL-1β release following 
LPS treatment and also preserved formation of new airways around the explant periphery. 
 
We previously observed that macrophage activation did not alter airway morphogenesis 
during early embryonal stages of development (< E16) (Stouch et al. 2014). Because 
inflammasome-mediated IL-1β release appeared to be required for abnormal lung 
morphogenesis, we hypothesized that developmental regulation of the inflammasome might 
determine when lung morphogenesis becomes sensitive to inflammatory stimuli. To further 
define the points during development when macrophage activation can influence lung 
morphogenesis, we used an inducible, constitutively active IKKβ mouse model (IKFM). In these 
mice, doxycycline induces expression of constitutively active IKKβ in Csf1r-expressing 
macrophages. Giving pregnant dams doxycycline from E14-E16 had no effect on fetal lung  
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Figure 4.2. Macrophage activation during the saccular stage of lung development is sufficient to 
inhibit airway morphogenesis during a window of susceptibility to inflammation. Pregnant mice 
were treated with doxycycline (2g/L) for 48h, from E14-E16, E16-E18, and E17-P1. E16 control 
and IKFM lungs did not have notable differences. Lung morphometry measurements show 
increased mesenchyme tissue and decreased airspace in E18 and P1 IKFM lungs. n = at least 5 
control and 5 IKFM lungs from 2 different litters, 20 images per lung, *p < 0.01. Images were 
obtained with a 20X objective. 
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airway morphology, but doxycycline from E16-E18 caused reduced airway branching and 
expansion in IKFM embryos compared to littermate controls (Figure 2A-B). Even more dramatic 
changes were seen in newborn IKFM pups following doxycycline treatment from E17-P1 
(Figure 4.2C). These data suggest NF-κB activation in macrophages is not capable of disrupting 
lung morphogenesis until E17-E18, when the developing lung transitions from the canalicular to 
saccular stage of development.  
 
Because IL-1β appears to be required to inhibit normal development, we hypothesized 
that the ability to release bioactive IL-1β via the inflammasome was developmentally regulated 
and did not occur until late in fetal development. To initially test this hypothesis, we measured 
expression of inflammasome components in fetal mouse lung tissue by immunostaining. 
Caspase-1 expression was detected in CD68+ macrophages throughout development, with 
increased immunostaining intensity in adult lung macrophages (Figure 4.3A). However, NLRP3, 
NLRP1a, and ASC were present in adult lung macrophages but not detected in fetal lung (Figure 
4.3B-D). Gene expression measurements confirmed developmental regulation of inflammasome 
components. ASC, Casp1, and Casp4, steadily increased during lung development (Figure 4.3E). 
Expression of the various Nod-Like Receptors and intracellular sensors detected was highest in 
postnatal day 1 and adult cells (Figure 4.3G). In addition to the inflammasome machinery, 
expression of the inflammasome substrates IL-1β, and IL-18 also increased during development 
with highest expression in postnatal and adult lung (Figure 4.3H). The additional findings that 
IL1R and TNFR expression increased with lung maturation suggested a comprehensive 
developmental regulation of the pulmonary innate immune system (Figure 4.3F).  
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Figure 4.3. Expression of the inflammasome is developmentally regulated. Frozen sections of 
fixed E13, E15, E18, and adult mouse lung were immunostained with antibodies against Casp1, 
NLRP1, ASC, and NLRP3. Macrophages were immunolabeled with CD68. Nuclei were labeled 
with DRAQ5. Images were obtained by laser scanning confocal microscopy. Scale bar, 50 μm. 
Gene expression of inflammasome components in E12, E13, E15, E17, P1, and adult lung. 
Expression of ASC, Casp4, and Casp1 increased incrementally throughout development. 
Expression of IL1R, IL1R2, and TNFR increased in saccular stage lung, beginning at E17 to 
adult. AIM2, NLRP1a, and NLRP14 had mostly consistent expression levels throughout 
development. NLRP3 and NOD2 had increased expression in saccular stage lung, beginning at 
E17 to adult. IL-1β, and IL18 increased after birth. n = 4 litters, pooled, from each embryonic 
time point or 4 individual lungs from P1 and adult, *p < 0.05. 
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But could the response to microbial products and TLR agonists also be developmentally 
regulated? To test this possibility, we added LPS to fetal lung explants from E13 and E15 NF-
κB-GFP-Luciferase (NGL) reporter mouse. Within 6 h, LPS induced GFP reporter expression 
throughout both E13 and E15 lungs (Figure 4.4A-B). Quantitative measurement of NF-κB-
dependent luciferase activity confirmed the response in E13 and E15 lungs, with higher relative 
levels in E13 lungs (Figure 4.4C). Therefore, the TLR-NF-κB axis was clearly functional as 
early as E13 and not likely responsible for the developmental window of susceptibility. 
Similarly, fetal lung mesenchymal cells targeted by inflammation were sensitive to soluble 
inflammatory mediators early in development. Primary cultures of E13, E15, and E18 NGL lung 
mesenchyme each responded to LPS, the TLR2 agonist Pam3CSK4, TNFα, and IL-1β (Figure 
4.4D). Interestingly, IL-18 had no effect. These data suggested that the early stage fetal lung has 
the capacity to respond to extracellular inflammatory signals. However, inflammatory 
macrophage activation can inhibit lung morphogenesis only later in development around the time 
of inflammasome expression and activity.  
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Figure 4.4. Early fetal mouse lung explants respond to LPS. Fetal NGL lungs, with NF-κB-
dependent GFP, were isolated and made into explants at E13 and E15. Explants were cultured 
with LPS. Increased GFP fluorescence was detected within 2h of LPS, but peaked at 6h, in both 
E13 and E15 fetal lung explants. GFP images were obtained on an EVOS Cell Imaging System 
using a 10X objective. NF-κB activation, measured by luminometry, is induced by LPS in E13 
and E15 explants. n = 6 explants from 3 separate litters. LPS (250ng/ml), Pam3Cys-Ser-(Lys)4 
(1ug/ml), TNFα (10ng/ml), and IL-1β (10ng/ml) activate NF-κB in fetal lung mesenchymal cells 
isolated from E13, E15, and E18 NGL lungs. IL18 (10ng/ml) stimulates NF-κB activation in E15 
and E18 mesenchymal cells. n = 4 separate litters, *p < 0.05. 
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We next tested if inflammatory signals and NF-κB activation could increase expression 
of the inflammasome and therefore accelerate the developmental process. To evaluate this 
potential priming mechanisms, we immunostained LPS-treated E15 fetal lung explants using 
antibodies against NLRP3. LPS did increase NLRP3 immunostaining but interestingly the 
expression remained restricted to CD68+ macrophages (Figure 4.5A). We obtained similar results 
in IKFM fetal lungs, with increased Casp1 expression in transgenic CD68+ macrophages (Figure 
4.5B). To test if activation could increase inflammasome expression in a cell autonomous 
manner, we isolated and cultured primary fetal lung macrophages. LPS increased expression of 
Casp1 in E18 and adult macrophages and increased Casp4 expression in E15, E18, and adult 
cells (Figure 4.5C). The effect of LPS on other components was variable. While LPS increased 
NLRP3 expression, activation had little effect on NLRC4 and actually decreased expression of 
ASC. Transgenic macrophage activation also had variable effects on inflammasome components, 
with increased Casp1 and Casp4 expression in IKFM macrophages but only increased Casp4 
expression in NLRP3L351PCreL cells (Figure 4.5D). Similarly, NLRC4 expression was increased 
in IKFM but not in NLRP3L351PCreL macrophages. Therefore while expression of some 
inflammasome components could clearly be induced by inflammatory activation, the effects 
were variable and gene specific. 
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Figure 4.5. Macrophage activation induces inflammasome expression in fetal mouse lungs. Fetal 
lung explants cultured with LPS for 24h and 72h were immunostained with NLRP3. LPS 
exposure induced NLRP3 speck formation in macrophages. Pregnant dams were give 
doxycycline from E12-E16 or E14-E18. IKFM fetal lungs isolated at E16 and E18 were 
immunostained for caspase 1. IKFM macrophages had increased caspase 1 expression. Images 
were obtained by laser scanning microscopy. Scale bar, 30 μm and 100 μm. Isolated 
macrophages from E15, E18, and adult lung exposed to LPS increased expression of the 
inflammasome components Casp1, Casp4, NLRP3, and NLRC4. Macrophages reduced 
expression in ASC in the presence of LPS. n = 3 litters or adult lungs. E18 IKFM macrophages 
have increased Casp1, Casp4, and NLRC4 expression. n = 4 control and 4 IKFM samples. E18 
NLRP3L351PCreL lungs have increased Casp4 and NLRP3 expression. n = 7 control and 7 
NLRP3L351PCreL lungs, *p < 0.05. 
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As fetal lung macrophages mature, cells gain F4/80 expression with similar to slightly 
lower CD11b expression. We previously demonstrated that NF-κB activation increased the 
percentage of CD11bloF4/80hi macrophages in the fetal lung, consistent with accelerated alveolar 
macrophage maturation (Stouch et al. 2014). To test if inflammasome activation could similarly 
increase fetal lung macrophage maturation, we used flow cytometry to identify different 
macrophage subtypes NLRP3L351PCreL lungs.  Among live, CD45+, CD68+ macrophages, fetal 
NLRP3L351PCreL mice had higher percentages of CD11bloF4/80hi macrophages compared to 
littermate controls (Figure 4.6A). In addition, these CD11bloF4/80hi macrophages expressed 
CD204 and CD206, consistent with alveolar macrophage maturation (Figure 4.6B). These data 
show that macrophages not only acquire inflammasome expression as they develop, but also that 
activation can influence development. 
 
  
	   103	  
  
	   104	  
Figure 4.6. Inflammasome activation induces maturation of fetal lung macrophages. E18 
NLRP3L351PCreL and control littermate fetal lungs were digested into single cell suspensions in 
preparation for flow cytometry. After doublet exclusion and selection for viable, CD45+, CD68+ 
cells, macrophages were gated for CD11b and F4/80 expression.  NLRP3 activation in 
macrophages increased the proportion of CD11bloF4/80hi macrophages in fetal lung. CD204 
expression increased in NLRP3L351PCreL CD11bloF4/80hi macrophages. NLRP3L351PCreL and 
control littermate CD11bloF4/80hi macrophages had similar CD86 and CD11c expression. 
NLRP3L351PCreL CD68+ macrophages had increased CD206 expression. n = 7 control and 7 
NLRP3L351PCreL lungs from 2 litters, *p < 0.01. 
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Discussion 
  
Our data show the important role of IL-1β in connecting the initial inflammatory 
response in lung macrophages to the developmental defects in airway morphogenesis seen when 
the fetal lung is exposed to inflammation and injury. While LPS can induce expression of 
multiple of inflammatory mediators, blocking IL-1 signaling, inhibiting inflammasome-mediated 
IL-1β cleavage, and genetic deletion of IL-1β each protected fetal mouse lung airway branching 
from inhibition by LPS. While other released inflammatory mediators can affect various 
developmental processes, the effects of LPS on formation and expansion of new saccular airways 
appears directly tied to IL-1β. Whether the importance of IL-1β over other inflammatory 
mediators is due to relative abundance, proximity to receptors on target cells, or other unique 
aspects of IL-1β biochemistry is not clear. The requirement of proteolytic IL-1β cleavage by the 
inflammasome identifies another intriguing mechanism regulating the lung innate immune 
response and a potential therapeutic strategy. 
 We showed that multiple gene components of the inflammasome are developmentally 
regulated. While immature fetal lung macrophages are capable of responding to LPS by 
activating NF-κB, the lack of a functional inflammasome prevents the release of bioactive IL-1β. 
The lack of inflammasome expression and/or function in immature macrophages may explain 
why NF-κB activation early in lung development fails to produce changes in lung 
morphogenesis. We show here that even E11 lung mesenchymal cells are very responsive to NF-
κB dependent inflammatory mediators, but the lack of an inflammasome appears to protect these 
cells from IL-1β exposure following macrophage activation. The transcriptional mechanisms 
regulating inflammasome component gene expression during development are not yet clear. 
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Interestingly, several genes were much higher in newborn and adult macrophages while other 
components were more consistently expressed throughout development. How inflammasome 
gene expression parallels the normal development of macrophages and other myeloid lineages 
also warrants further investigation. 
 Previously we demonstrated that increased IKKβ activity and NF-κB activation in 
developing lung macrophages increased expression of more mature alveolar macrophage 
markers (Stouch et al. 2014). Here we observed similar results with gain of function 
inflammasome mutant mice, with increased percentages of CD11bloF4/80hi macrophages. Fetal 
lung NLRP3L351PCreL macrophages also expressed higher levels of CD204 and CD206, both 
expressed on more mature alveolar macrophages. We speculate that IL-1β may function in a cell 
autonomous manner in fetal lung macrophages to accelerate the maturation process. How IL-1β 
affects macrophage function and biology in response to a second activating stimulus or in their 
role healing wounds and injury remains unknown. We have also not yet completely characterized 
the contribution of recruited fetal monocytes to this maturation of the lung macrophage 
populations. 
 Identifying inflammasome expression, function, and IL-1β release as important 
mechanisms linking inflammation and abnormal development opens new therapeutic 
possibilities. Perhaps blocking IL-1β signaling or inflammasome function in specific cell 
populations could prevent the negative effects of inflammation on lung development seen in 
patients with BPD. Subsequent studies will need to test if targeting macrophages or lung 
mesenchyme and epithelia will be feasible strategies. In addition, we do not yet know if 
accelerated macrophage maturation following inflammation is beneficial or detrimental to the 
developing lung innate immune system. Also, strategies to prevent the inflammation-induced 
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expression of inflammasome components in immature macrophages could be protective for the 
developing lung or could prevent the preterm lung from properly killing inhaled pathogens and 
removing aerosolized particles. 
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CHAPTER V 
 
Conclusions and Future Directions 
 
 Our goal of this research was to advance the understanding of fetal lung inflammation. 
Before our research, different cell types had been suggested as initiating and propagating 
inflammation in the fetal lung. It was also unclear, although our evidence suggested, as to which 
inflammation pathway was responsible. We began by asking: How does the inflammatory 
response begin in the fetal lung? Are macrophages present and responsible for inflammatory 
signaling? Is it the NF-κB pathway that is the primary signaling pathway involved? Are fetal 
lung macrophages responsive to polarization stimuli? Do fetal lung macrophages change their 
phenotype during inflammation? In order to answer these questions, we would: identify the cells 
responsive to LPS in the fetal lung; determine if macrophage activation, through inducing NF-
κB, was required for the inflammatory response and its effects on lung development; and 
determine if macrophage activation changed fetal lung macrophage phenotype. 
 
What cell type initially responds to LPS in the fetal lung and is that cell type responsible for 
abnormal lung branching after exposure to LPS? 
 To identify which cells in the fetal lung first responded to LPS, we used the NF-κB 
reporter mouse (NGL) to detect GFP expression after NF-κB activation. We isolated fetal lung 
explants from NGL mice and treated them with LPS. This allowed us to identify the cells that 
first activate NF-κB through the colocalization of GFP with cell-specific markers, such as CD68. 
Since macrophages were the first cell type to respond to LPS, we then wanted to test if 
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macrophages had a role inhibiting airway branching. Using clodronate to deplete macrophages in 
fetal lung explants, there was normal airway branching after LPS exposure. These results suggest 
macrophages are the cell type in the fetal lung that begin inflammatory signaling in response to 
LPS and are required to induce abnormal airway branching. 
 
Do macrophages require NF-κB activation to disrupt lung development? 
 To determine if the NF-κB pathway in macrophages drives fetal lung inflammation, we 
isolated fetal lung explants from mouse models that would either inhibit or activate NF-κB solely 
in macrophages. LysM-Cre:IKKβf/f fetal lung explants were protected from the effects of LPS, 
while Cfms-rtTA:Tet-O-Cre-cIKKβ (IKFM) fetal lung explants had inhibited airway branching. 
Using whole sections of saccular-stage IKFM fetal lungs, we observed reduced airspace and a 
thickened mesenchyme. These results confirm that macrophages are sufficient to inhibit lung 
development, and NF-κB is the inflammatory pathway utilized by fetal lung macrophages. 
 
Can fetal lung macrophages change phenotype? 
 We first identified and measured a panel of recognized M1 and M2 phenotype markers 
during normal lung development. RT-PCR and immunofluorescence imaging showed increased 
expression of macrophage phenotype markers during later stages of embryonic development, 
immediately after birth, and in adult macrophages. In vitro exposure to LPS, IL-4, or IL-13 
increased expression in M1 or M2 markers in fetal lung macrophages. However, flow cytometry 
of E18 IKFM lungs showed macrophages did not exclusively increase M1 markers. Instead, 
IKFM lung macrophages had an increased population of CD11bloF4/80hi cells, in addition to 
increased CD204 and CD206 expression. Mature, alveolar macrophages express higher levels of 
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CD204 and CD206 (Zaynagetdinov et al. 2013). While we expected fetal lung macrophages to 
follow typical polarization expression patterns, our results showed that fetal lung macrophages 
begin a maturation process after NF-κB activation. 
 
Is IL-1β the primary proinflammatory cytokine that disrupts fetal lung development? 
 To determine if IL-1β was a necessary factor to disrupt lung development, we treated 
fetal lung explants with an IL-1β neutralizing antibody in the presence of LPS. Inhibiting IL-1β 
activity protected fetal lung explants from LPS. Using an IL1β-/- mouse model, airway branching 
in fetal lung explants was protected from LPS. This data supports the idea that IL-1β is the 
primary factor causing abnormal fetal lung development during inflammation. 
 
 Overall, this research has shown multiple ways that fetal lung macrophages respond to 
inflammation. NF-κB activation, whether through LPS signaling or cIKKβ, increases fetal lung 
macrophage recruitment, proliferation, and maturation (Figure 5.1). Activated fetal lung 
macrophages increase expression of chemokines. These chemokines recruit additional immune 
cells to the fetal lung. IKFM lungs have an influx of monocytes. IKFM lungs also have increased 
numbers of PHH3+ and Ki67+ macrophages.  
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Figure 5.1. Fetal lung macrophage response to inflammation. Fetal lung macrophages can 
become activated through LPS signaling, NF-κB activation, and inflammasome activation/IL-1β 
signaling. Macrophage activation leads to increased proliferation, increased recruitment through 
chemokine expression, and maturation.  
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Inflammasome activation or cIKKβ in fetal lung macrophages increases the proportion of  
CD11bloF4/80hi macrophages, and, along with increased expression of CD204 and CD206, 
indicates a maturation of fetal lung macrophages.   
Our research on fetal lung macrophages can contribute to the search for more effective 
prevention and treatment options for infants with BPD. We have shown a clear relationship 
between fetal lung macrophages, altered lung development, and IL-1β signaling. New therapies 
could target fetal lung macrophages by intervening during their activation. Our research can be 
used as supporting data to begin studies on macrophages isolated from infants with BPD. Fetal 
macrophages from BPD patients could be treated with new therapies targeting macrophages and 
their released factors. The responsiveness of macrophages directly isolated from BPD patients 
would be an indicator of potentially viable treatment options.  
 Our interest in fetal macrophage biology and the role of macrophages in the fetal lung has 
only increased. There are many directions to follow in our future research. Some of the guiding 
questions are: Do fetal lung macrophages need to undergo maturation prior to releasing 
proinflammatory cytokines? What factors control fetal macrophage maturation? Can macrophage 
maturation be prevented, which in turn could prevent the release of proinflammatory cytokines? 
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Future Directions 
 
Determine if NF-κB regulates transcription factors that induce fetal macrophage 
maturation. 
 PU.1 and M-CSF are required factors for normal macrophage development. PU.1 is 
necessary for myeloid progenitor cell differentiation and is a regulator of Csf1r transcription, the 
corresponding receptor for M-CSF (DeKoter et al. 1998; DeKoter et al. 2000; Zhang et al. 1994). 
M-CSF is required throughout macrophage development from their early monocyte precursors 
(Becker et al. 1987). Another role for PU.1 is acting in macrophages as an initiator of 
macrophage specific genes (Ross et al. 1998). The network of genes that PU.1 regulates includes 
Myb, Egr2, Ly96, Foxp1, and KLF4 (Weigelt et al. 2009; Shi et al. 2008; Feinberg et al. 2007). 
In alveolar macrophages, GM-CSF regulates PU.1 expression (Shibata et al. 2001). GM-CSF is 
required for normal levels of PU.1 and normal functioning of alveolar macrophages (Shibata et 
al. 2001). Currently, it is unclear how inflammation influences any of the factors involved in 
fetal macrophage maturation.  
NF-κB activation in macrophages during fetal lung development increased the 
CD11bloF4/80hi subpopulation. This indicates NF-κB may have a role in regulating the 
transcription factors that control macrophage maturation. In preliminary searches, we have 
identified NF-κB binding sites in the promoters of macrophage differentiation genes PU.1 and 
Csf1r and in the macrophage matrix metalloproteinase MMP12. Early data of isolated 
macrophages from IKFM and control littermate lungs show increases in PU.1 expression, along 
with increases in the PU.1 targets MMP12 and Csf1r (Figure 5.2). Further experiments should 
use ChiP assays to confirm the presence of NF-κB within these genes’ promoters. 
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Figure 5.2. NF-κB increases expression of genes involved with macrophage maturation. 
Macrophages were isolated from E18 fetal lungs (dox E14-E18). Gene expression was measure 
by RT-PCR. NF-κB increased expression of PU.1, Csf1r, and MMP12 in fetal lung 
macrophages. 
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An important experiment to link macrophage maturation with inflammation is to analyze 
macrophage subpopulations in fetal lungs isolated from LysM-Cre:IKKβf/f. Macrophages 
residing in LysM-Cre:IKKβf/f fetal lungs will have inhibited NF-κB activation. If NF-κB is 
required for macrophage maturation under basal conditions, we would expect to see a reduced 
proportion of the CD11bloF4/80hi subpopulation. Further fetal lung macrophage subpopulation 
analysis could be done on a global scale, where IKFM macrophages are separated by FACS and 
are analyzed by RNA-SEQ. RNA-SEQ would show differences in expression of maturation-
associated transcription factors that are regulated by NF-κB.  
 
Determine if fetal lung macrophage subpopulations have different roles in lung 
development and the inflammatory response. 
 In adult lung, alveolar macrophages, interstitial macrophages, and monocytes each have a 
unique signature of markers. Alveolar macrophages are recognized as CD68hiCD11b-F4/80+, 
while interstitial macrophages are CD68loCD11b+F4/80- (Zaynagetdinov et al. 2013). 
Macrophages in different niches within the adult lung have different marker expression profiles 
and may have separate functional roles as well. Marker expression corresponds to subsets in fetal 
lung macrophages, which can be divided into CD11bhiF4/80lo and CD11bloF4/80hi. It is unknown 
if separate subpopulations in the fetal lung have distinct micro-locations or functions (Figure 
5.3).  
Fetal lung macrophages are clustered around blood vessels, adjacent to elongating airway 
tips, or throughout the mesenchyme. Lineage tracing of the CD11bhiF4/80lo and CD11bloF4/80hi 
subsets simultaneously would identify micro-locations in the fetal lung to which specific 
macrophage populations are restricted. Identifying the micro-location of fetal lung macrophages  
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Figure 5.3. Fetal lung macrophages may have different roles that are niche specific. Future 
studies on macrophage function in the fetal lung should focus on the roles of the multiple 
macrophage subpopulations present. Macrophage subsets may have overlapping functions and 
unique, separate functions. Early macrophage maturation in response to inflammation may alter 
the function of lung macrophages, leading to disrupted lung development. Preliminary data 
suggests that CD11bloF4/80hi macrophages are responsible for the production of the 
proinflammatory cytokine IL-1β.  
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may lead to experiments determining unique functions of the subpopulations. Further, 
observation of both subpopulations in real time would provide new information determining if 
there are fluctuations of individual cells between subsets or if there is permanent subset 
specification during development. By isolating both CD11bhiF4/80lo and CD11bloF4/80hi, the 
phenotype of fetal lung macrophages may be further defined. 
Previously, separation of fetal IKFM CD11bhiF4/80lo and CD11bloF4/80hi macrophages by 
FACS showed gene expression differences between these subpopulations. CD11bloF4/80hi 
macrophages had increased expression of IL-1β compared to the CD11bhiF4/80lo subpopulation. 
A higher level of IL-1β in these macrophages may indicate a primed state that will facilitate a 
faster inflammatory response in the event of infection. CD11bloF4/80hi macrophages also had 
increased cyclinD1 expression, which is a marker of mitosis. As the fetal IKFM CD11bloF4/80hi 
subset shares similar characteristics with mature macrophages, we speculate that this population 
may require enhanced proliferative ability in order to propagate the future airspace macrophages. 
Future research should focus on differences between the two macrophage subpopulations, 
including inflammasome activation and proinflammatory cytokine production.  
 Different subpopulations may each have separate, unique functions. Functions of fetal 
macrophages could include fighting infection, clearing debris and dying cells, and releasing 
growth factors that influence other cell types. Whether inflammation alters the role of both 
populations has yet to be answered. Isolating macrophage subpopulations from IKFM and 
NLRP3 lungs by FACS could identify differences between the macrophage subsets. We could 
use an IL-1β ELISA to show if either subpopulation releases significantly higher amounts of IL-
1β protein. We suspect the CD11bloF4/80hi subpopulation may have increased inflammasome 
formation and IL1β release, as maturation of monocytes into macrophages leads to NF-κB 
	   119	  
accumulation in the cell cytoplasm and a stronger response to LPS (Takashiba et al. 1999). We 
could use in vitro assays to measure the efficiency of phagocytosis and efferocytosis of the 
separated subpopulations. Analyzing gene expression of VEGF, MMPs, Wnt ligands, and TGF-β 
in separate macrophage subpopulations could more clearly define the signaling relationships 
between the many cells that are present in the fetal lung. Tissue macrophages have the ability to 
guide angiogenesis with VEGF production, construct or degrade extracellular matrix, and 
provide growth factors for stem cells (Mantovani et al 2012). Macrophage-released Wnt7b also 
contributes to epithelial cell repair in injured kidneys (Lin et al. 2010). Inflammation could have 
a large role in regulating growth factor expression and release by fetal lung macrophages. 
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